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I REVIEW OF THE LITERATURE  
 
1. Introduction  
 
A cell is capable of synthesising tens of thousands of different molecules. An 
important challenge in cell biological studies has been to figure out how these 
molecules are transported to their destinations, such as to the cell organelles where 
they act to maintain cellular homeostasis. In the early 1950’s, electron microscopy 
provided scientists with the possibility to study the internal structures of the cell and 
to observe the fine membranes that surround cell organelles. Maintenance of the 
functional identity of these organelles requires effective as well as selective sorting 
and delivery of organelle constituents. In addition, many nutrients and signalling 
molecules are taken into the cell from the extracellular space and a portion of the 
newly synthesised proteins are transported out of the cell.  
 
 
 
Figure 1. The intracellular compartments of eukaryotic cells involved in endocytic and secretory 
pathways. Molecules are taken up from the plasma membrane by endocytosis and are transported via 
early (EE) and late (LE) endosomes to several different intracellular compartments, or recycled back to 
the cell surface. In the secretory pathway, cargo molecules are transported from the endoplasmic 
reticulum (ER) through the Golgi to the plasma membrane or to endosomes/lysosomes. Transport is 
mediated via transport vesicles that bud off one membrane and fuse with another. 
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  Proteins that are destined for the secretory pathway are translated at the 
endoplasmic reticulum (ER) bound ribosomes. ER is the large membrane organelle 
responsible for correct folding of proteins and the addition of N-linked 
oligosaccharides. From the ER a major portion of proteins travel in vesicular carriers 
to the Golgi apparatus where sugar residues are further modified and O-linked 
glycosylation takes place. In the last part of the Golgi, the trans-Golgi network 
(TGN), cargo molecules are packaged again into transport vesicles. The vesicles are 
transported to different cell organelles: to lysosomes (or vacuoles), to endosomes, 
back to the Golgi or ER, or to the plasma membrane where uptake of material from 
the extracellular space also occurs. This trafficking is called intracellular membrane 
traffic or vesicle transport. Only the trafficking to the cell nucleus, mitochondria or 
peroxisomes (and chloroplasts in plants) is excluded from this concept (Fig.1) 
(reviewed by Mills et al., 1999; Pfeffer, 2003; Waters and Hughson, 2000).  
   
 
 
Figure 2. The five stages of a membrane trafficking event. 1. Cargo selection. 2. Coat and vesicle 
formation. 3. Movement of a vesicle along microtubular elements by motor proteins from the donor to 
the acceptor compartment. 4. Vesicle tethering and docking. 5. Fusion 
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  In vesicle transport, the specificity of delivery is absolutely crucial for 
maintaining the proper function of cell organelles. Protein trafficking requires a series 
of fast events that include cargo selection, vesicle budding at the donor organelle, and 
finally docking and fusion of the transported vesicles with the target organelle (Fig.2). 
The secretory pathway (transport from the ER towards the plasma membrane) and the 
early steps of endocytosis (uptake of material from the plasma membrane and 
homotypic endosome-endosome fusion) are two well-characterised transport 
processes (reviewed by Mills et al., 1999; Pfeffer, 2003; Waters and Hughson, 2000). 
Also, the release of neurotransmitters in synaptic terminals has been intensively 
studied (reviewed by Burgoyne and Morgan, 2003). 
  The main features of the membrane trafficking process were already 
characterised in 1974 when George Palade, Albert Claude and Christian de Duve were 
awarded the Nobel Prize for their work on the intracellular aspects of the process of 
protein synthesis. Since then, scientists have been working towards identifying 
precisely how the protein transport machinery works. The major experimental studies 
in this field have been made in Saccharomyces cerevisiae and nerve cells. In 1993, 
James Rothman’s group proposed a working model, the SNARE (soluble NSF 
attachment protein (SNAP) receptor) hypothesis, which contained the idea of how one 
cell can transport such a huge amount of molecules into correct target organelles 
(Söllner et al., 1993b). SNARE-complexes are still believed to be the central 
machinery in membrane fusion and SNARE proteins are, at the moment, the most 
widely studied proteins in membrane trafficking. The main features of the vesicle 
transport process have mostly been elucidated; however, many mysteries still remain 
unsolved. 
 
 
2. Membrane trafficking 
 
2.1 Vesicle formation 
 
Only a subset of proteins and lipids are allowed to enter each transport vesicle. Coat 
protein complexes assemble on membranes at a site of vesicle formation and 
participate in cargo selection. During the formation of the transport vesicle, a limited 
set of coat proteins carry out a programmed set of sequential interactions that lead to 
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vesicle budding from the parent membrane, and later, vesicle uncoating and fusion 
with the target membrane. Carrier vesicles can be identified by their coats; COPI (coat 
protein complex I), COPII (coat protein complex II) or clathrin. There are clear 
similarities and differences between the behaviour of these coat protein systems. 
There are also many transport routes with yet unknown carrier vesicles (reviewed by 
Rothman and Wieland, 1996; Springer et al., 1999).   
 COPII vesicles transport proteins from the ER to the Golgi. The COPII coat 
system was initially identified in S. cerevisiae, but the homologous protein 
components have also been identified in mammalian cells, in which the same 
nomenclature as in yeast is used. The COPII coat consists of the small GTPase Sar1p 
and the heterodimeric protein complexes Sec23/24p and Sec13/31p. These proteins 
are necessary for COPII vesicle formation and work together with other cytosolic 
factors or membrane proteins required for targeting and fusion (Barlowe et al., 1994). 
The Sec23p-Sec24p complex is the component responsible for cargo recognition. 
Sar1p-GTP facilitates the association of the Sec23p-Sec24p complex with cargo 
proteins and also activates Sec23p to bind SNARE proteins involved in the specificity 
of vesicle targeting (Springer and Schekman, 1998). The Sec13/31p complex is 
presumably involved in membrane curvature and vesicle budding (Antonny et al., 
2001). 
The transport route that moves proteins from the Golgi back to the ER is one 
of the intracellular retrograde transport routes. This route is operated by COPI 
vesicles.  COPI coatomer is a complex of seven proteins. COPI coated vesicles 
capture proteins that carry a sorting signal in their cytoplasmic carboxyl-terminal 
domain (KKXX, KXKXX, RRXX where X is any amino acid) (Cosson and 
Letourneur, 1994). Soluble ER resident proteins contain a short retrieval signal at 
their C-terminal end, called KDEL-sequence (Munro and Pelham, 1987). COPI 
vesicles use another small GTPase, ARF1, for budding of the vesicle. In the GTP-
bound state, ARF1 is myristoylated and becomes membrane bound. The hydrolysis of 
GTP to GDP releases ARF1 from the membrane and acts as a timer (as with Sar1p 
and COPII vesicles), triggering the release of other coat components and preparing the 
vesicle for fusion (Goldberg, 1999). COPI vesicles also transport cargo molecules 
within the Golgi complex (Orci et al., 1997). 
Clathrin coated vesicles bud from the plasma membrane and are transported to 
endosomes. Vesicles transported from the TGN to endosomes also have clathrin coats. 
 11
Many membrane proteins with their ligand, like the LDL (low density lipoprotein) 
receptor (Bos et al., 1995), are internalised by the clathrin pathway (Payne and 
Schekman, 1985). Yeast cells also use a clathrin-based pathway, although the use of 
clathrin in the secretory pathway appears more prominent than in the endocytic 
pathway (Tan et al., 1993). Clathrin is the most abundant protein in the coat of 
endocytic vesicles and more than 25 proteins have been identified as its partners in the 
endocytic pathway alone. So, in contrast to COPI and COPII vesicles, clathrin coated 
vesicles have a large variety of associated proteins. Clathrin coated vesicles from the 
TGN carry AP-1 (adaptor protein complex 1), and vesicles from the plasma 
membrane carry AP-2 (adaptor protein complex 2). AP-1 and AP-2 adaptors bind to 
specific sorting signals found in the cytosolic tails of a large number of membrane 
proteins (reviewed by Lafer, 2002). Adaptor protein complexes 3 and 4 are also found 
and located in the TGN and on endosomes. AP-3 also associates with clathrin 
(Dell'Angelica et al., 1998). AP-4 does not bind clathrin and recognises cargo that has 
tyrosine-based motifs at the TGN (Hirst et al., 1999). In the plasma membrane, 
arrestins are a second type of adaptor in clathrin coated pits. ?-arrestin couples 
directly with clathrin and recruits seven-transmembrane-helix G-protein-coupled 
receptors together with AP-2  (Goodman et al., 1996).  
 
2.2 Movement of vesicles from the donor to the acceptor membrane 
 
The cytoskeleton is a crucial component of the membrane trafficking machinery. 
Organelles and vesicular transport intermediates are localised along microtubules. 
Microtubules are formed via head-to-tail association of tubulin proteins that form 
polar filaments. The tubulin subunit is itself a heterodimer and has a binding site for 
GTP at both ends of the dimer. At one end, GTP is physically trapped and is never 
hydrolyzed or exchanged, while at the other end the GTP is exchangeable to GDP, 
which has an important effect on microtubule dynamics. Each protofilament in a 
microtubule is assembled from subunits that all point in the same direction to create 
two ends, the minus and the plus end. Protofilaments themselves are aligned in 
parallel. In non-polarised cells, the relatively stable minus ends of microtubules are 
located at the cell center near the centrosomes, whereas the dynamically growing plus 
ends extend to the cell periphery (reviewed by Kamal and Goldstein, 2000).  
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In polarised epithelial cells, the plus ends of microtubules are localised at the 
basolateral terminus of the cell and the minus ends at the apical side. In non-polarised 
cells, the ER and early endosomes are usually dispersed towards the plus ends of 
microtubules at the cell periphery, whereas the Golgi apparatus, late endosomes and 
lysosomes are often clustered near the minus ends at the cell center. Actin filaments 
are localised at the cell surface and act as actin cables within the cell. This distribution 
of organelles is thought to promote efficient vesicle transport by using cytoskeletal 
motor proteins (reviewed by Kamal and Goldstein, 2000). 
 Kinesins and cytoplasmic dyneins are microtubule-based motor protein 
families that transport vesicles by using ATP hydrolysis as an energy source. Both 
kinesin- and dynein-driven vesicle motility have been shown to require additional 
protein accessory factors (Schroer and Sheetz, 1991). Kinesin superfamily members 
play an important role in post-Golgi transport (Rahman et al., 1999) and in neurons 
with fast anterograde transport that moves cargo from the cell body to the synapse 
(reviewed by Goldstein and Yang, 2000). Cytoplasmic dynein is a minus-end directed 
motor that facilitates the inward movement of endocytic vesicles from early to late 
endosomes by associating with the dynactin complex (Aniento et al., 1993; Holleran 
et al., 1998). Myosins are motor proteins responsible for actin-based movement. The 
myosin superfamily consists of 15 families of related proteins in eukaryotic cells, and 
some of them have been localised on endocytic organelles (Raposo et al., 1999). 
Several motor protein binding partners that are involved in vesicle cargo selection or 
in linking the cytoskeleton to organelles have been found (see Rab proteins in chapter 
3).  Many key issues, however, must be solved: How is the motor activity regulated, 
and are specific motor proteins required for each membrane sorting step (reviewed by 
Kamal and Goldstein, 2000)? 
 
2.3 Tethering, docking and priming 
 
While motor proteins transport the vesicle along cytoskeletal tracks close to the target 
membrane, numerous proteins and protein complexes also direct different classes of 
vesicles to their appropriate target membrane. Attachment to the membrane before 
fusion requires several layers of protein-protein interactions. When talking about this 
issue, scientists often use terms that are somewhat puzzling. Tethering means that a 
vesicle already has a connection to the target membrane through tethering proteins or 
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protein complexes but is still quite far from the membrane (>25nm). Docking means 
that the vesicle is closer (<5-10nm) and tightly associated with the target membrane. 
This type of interaction may still be reversible. Stable docking probably represents 
several distinct molecular states before fusion (reviewed by Pfeffer, 1999). The term 
priming is used in neural and neuroendocrine systems where docked vesicles are not 
intrinsically fusion competent. Priming events are considered to be those that render 
docked vesicles competent for Ca2+ -triggered fusion (reviewed by Klenchin and 
Martin, 2000).  
Vesicle tethering is a SNARE-independent event and requires several protein-
protein interactions. These interacting proteins are called tethering factors and seem to 
be coordinated by Rab-GTPases (Zerial and McBride, 2001). Different 
tethering/docking factors are localised on various organelles inside the cell, mediating 
the specificity of each transport route. Tethering is typically mediated by long helical 
proteins or large protein complexes that are recruited from the cytosol to the site of 
vesicle–target membrane contact (reviewed by Guo et al., 1999). EEA1 (early 
endosomal antigen 1) is a well-characterised tethering/docking factor. EEA1 is a large 
endosomal coiled-coil forming protein, which regulates endosomal trafficking 
together with Rab5 and its other effector proteins (see chapter 3.1.2.). The association 
of EEA1 with the endosomal membrane requires Rab5-GTP and the activity of 
phosphatidylinositol-3-kinase (PI(3)K). PI(3)Ks are a subfamily of lipid kinases that 
catalyse the addition of a phosphate molecule specifically to the 3’ position of the 
inositol ring of phosphatidylinositol (PI). EEA1 contains binding domains for both the 
Rab5-GTP and the PI(3)K lipid product phosphatidylinositol-3-phosphate (PI(3)P). 
The interaction with GTP bound Rab5 involves the N-terminal C2H2 zinc-finger motif 
of EEA1. There is also another binding site for Rab5 in the C-terminal part of EEA1. 
The PI(3)P binding domain is called the FYVE finger domain and this creates an 
important link between membrane trafficking and cell signalling, a role of PI(3)P that 
is well characterised (Simonsen et al., 1998).  
In the Golgi apparatus, the tethering factor p115 links COPI coated vesicles to 
the Golgi membrane. p115 also links together several other Golgi proteins (like 
GM130, Giantin, Rab1) and stimulates the specific assembly of the Golgi SNARE 
complexes (Shorter et al., 2002). There are several identified Golgi tethering 
complexes in yeast S. cerevisiae. The transport protein particle (TRAPP) complexes 
are conserved tethering complexes in the secretory pathway of yeast. TRAPP I is a 
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specific receptor for ER-derived COPII vesicles. After the vesicle binds the complex, 
the small GTPase Ypt1p (a Rab protein) is activated by TRAPP I and then other 
tethering factors are recruited. TRAPP II contains an additional three subunits and 
acts within the Golgi transport (Sacher et al., 2001). Another tethering complex, 
called exocyst, is an eight-subunit complex involved in tethering of exocytic vesicles 
to the plasma membrane. It is found in both yeast and mammalian cells (in 
mammalian cells the exocyst is also called the Sec6/8 complex). The exocyst is 
regulated by five different GTPases, which are members of Rab, Rho and Ral 
families. At the cell surface, the exocyst is localised to the regions of active 
exocytosis, like the bud tip in yeast or the tip of growing neurites (reviewed by 
Lipschutz and Mostov, 2002). In addition, the conserved oligomeric Golgi (COG) 
complex (also known as Sec34/35, GTC or ldlCp) and the Golgi-associated retrograde 
protein (GARP) complex (also known as Vps52/53/54 or VFT) act as Golgi tethering 
complexes in yeast. The COG complex is involved in the recycling of Golgi elements 
and the GARP complex is required for retrograde transport from endosomes to the 
Golgi (reviewed by Whyte and Munro, 2002). 
 
2.4 Fusion 
 
N-ethylmaleimide sensitive fusion protein (NSF) (Block et al., 1988) and soluble NSF 
attachment proteins (SNAPs) (Clary et al., 1990) were found to be important factors 
in membrane trafficking. The secretory defects observed earlier in sec18 and sec17 
mutant strains, respectively, are due to mutations in the homologous yeast genes 
(Clary et al., 1990; Novick et al., 1980; Wilson et al., 1989). Characterisation of these 
proteins led to the identification of a set of membrane proteins called SNAP receptors 
(SNAREs). SNARE proteins not only served as a binding site for NSF and SNAP but 
were also thought to mediate the specificity of vesicle docking and fusion. SNARE 
proteins, together with NSF and SNAP, formed a complex (the 20S fusion particle) 
that seemed to be a core element of the membrane fusion machinery. These findings 
led to the SNARE hypothesis, a theory in which SNAREs are responsible for the 
specificity of vesicle trafficking and are possibly involved in the actual fusion process 
(Söllner et al., 1993b). Distinct SNAREs are localised to distinct membrane 
compartments and domains in all eukaryotic cells. Individual SNARE proteins form 
specific complexes in the organelle where they are located. Complexes are formed 
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between the single transport vesicle and the target membrane. With the help of Rab 
and Sec1 proteins (and other regulatory proteins) SNAREs can make the transport 
highly specific for one transport route.  
SNARE proteins are classified in two groups: SNARE proteins on transport 
vesicles (v-SNAREs) and those on target membranes (t-SNAREs). They are integral 
membrane proteins with a single transmembrane domain at the C-terminus. They 
contain the characteristic SNARE domains of ?-helical repeats ~60 amino acids in 
length that form coiled coil structures. Through these coiled-coil structures, SNARE 
proteins form extremely stable complexes that bring vesicle and target membranes 
close together (Rothman, 1994). SNAP-25-like t-SNARE proteins form an exception 
to other SNARE proteins in their structure. These proteins are anchored to membranes 
via palmitic acid modification and yet still participate in the SNARE complex 
formation by using two ?-helical segments, whereas other SNAREs participate only 
with one segment (Hess et al., 1992). In the SNARE complex, the four ?-helical 
segments are in register so that in a highly conserved layer of amino acid residues 
there are three glutamine (Q) residues and an arginine (R). Based on this structural 
definition, the SNARE proteins can also be classified as Q- or R-SNAREs. The fusion 
competent SNARE complexes consist of four-helix bundles composed of three Q-
SNARE helices and one R-SNARE helix (Fasshauer et al., 1999; Fasshauer et al., 
1998). The same structural features have been observed in SNARE complexes of 
different membrane compartments even though the complex in some cases consists of 
four SNARE proteins instead of the more common three proteins (Antonin et al., 
2000). After fusion, NSF and SNAP are needed for the disassembly of the so-called 
cis-SNARE complex arising during fusion (Söllner et al., 1993a). 
SNARE complex formation is most widely studied using neuronal SNARE 
proteins. Three SNARE proteins are involved in this process: one v-SNARE on the 
synaptic vesicle membrane (VAMP-2) and two t-SNAREs on the target membrane 
(SNAP-25 and Syntaxin1A). SNAP-25 contributes two SNARE domains in complex 
formation, while Syntaxin1A and VAMP-2 both contribute one domain. Due to 
coiled-coil formation of SNARE motifs, the synaptic vesicle is pulled closer to the 
presynaptic plasma membrane, thereby enabling it to fuse (reviewed by Lin and 
Scheller, 2000) (Fig.3). When liposomes containing VAMP-2 are mixed with 
liposomes containing SNAP-25 and syntaxin 1A, membrane fusion is observed 
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(Weber et al., 1998). While this suggests that SNAREs are the minimal machinery for 
fusion, if only the rate of fusion in vitro is far from the physiological rate in synaptic 
terminals (Fasshauer et al., 2002). It is now evident that the SNARE complex is 
capable of overcoming biophysical barriers of fusion. Remarkable structural 
similarities between the fusogenic state of viral fusion proteins and the core SNARE 
complex suggest a related function (reviewed by Skehel and Wiley, 1998). In vitro, 
liposome studies also show that the complex is formed and causes fusion when the v-
SNARE is on one membrane and the t-SNARE is on the other, indicating specificity 
of membrane fusion (Parlati et al., 2000). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A schematic presentation of SNARE complex function. SNARE complexes are formed 
from SNARE proteins, which each contribute one or two ?-helical subunits of the complex. The 
subunits form a coiled-coil structure that pulls the vesicle close to the target membrane and allows the 
membranes to fuse. 
  
Cell biological studies in vivo, however, indicate that SNAREs alone cannot be 
responsible for fusion specificity. Certain SNAREs mediate more than one transport 
step and incorporate into more than one SNARE complex (Fischer von Mollard and 
Stevens, 1999). Furthermore, Drosophila syntaxin 1A is expressed throughout the 
axonal plasma membrane, yet synaptic vesicles only fuse with the plasma membrane 
at the synapse (Schulze et al., 1995). Also S. cerevisiae’s syntaxin proteins, Sso1p and 
Sso2p (Aalto et al., 1992), are located around the yeast cell while the actual secretion 
site is only a small part of the plasma membrane (Brennwald et al., 1994). According 
Membrane
Transport vesicle
Syntaxin1A (t-SNARE)
SNAP-25  (t-SNARE)
VAMP1 (v-SNARE) Cargo molecules
Coiled coil SNARE complex
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to Fasshauer and colleagues, cognate and non-cognate SNARE complexes share 
similarities in their biophysical properties, suggesting the unlikelihood that specificity 
of membrane trafficking is due to intrinsic specificity of SNARE pairing (Fasshauer et 
al., 1999). These observations imply that SNAREs alone do not provide the level of 
specificity that is needed in vesicle trafficking. Additional factors must be required. 
The main regulatory protein families for SNARE complex formation/function include 
the Rab protein family and the SM related proteins (see chapters 3.1. and 3.2.). The 
surface of the SNARE complex provides several binding sites for other binding 
partners and regulators (Antonin et al., 2002). Proteins that interact with SNAREs, 
many of which may facilitate complex formation, are still being discovered today.  
 
 
3. SNARE complex regulators  
 
3.1 Rab proteins 
 
3.1.1 General features of Rab proteins 
 
The term ‘Rab’, meaning ‘Ras-related in brain’, was first introduced in 1987 when 
four new members of the ras gene family were identified in rat brain (Touchot et al., 
1987). Today, the Rab GTPase family is considered one of the most important 
regulatory protein families in membrane trafficking. There are 11 Rab (Yptp/Sec4p) 
proteins expressed in the yeast Saccharomyces cerevisiae and over 60 family 
members in humans. Rab proteins are widely distributed throughout the cytosolic face 
of distinct intracellular membrane compartments, and some Rabs are cell type or 
tissue specific (Fig.4).  
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Figure 4. Rab protein localisation in mammalian cells. Some proteins are cell- or tissue-specific (e.g 
Rab17 in epithelia) or show cell type specific localization (e.g Rab13 in tight junctions). Symbols in the 
picture are: CCV, clathrin coated vesicle; CCP, clathrin coated pit; EC, epithelial cell; IC, ER-Golgi 
intermediate compartment; M, melanosomes; MTOC, microtubule-organizing centre; SG, secretory 
granule; SV, synaptic vesicles; T, T-cell granules; TGN, trans-Golgi network (From Zerial and 
McBride 2001). 
 
Rab proteins regulate membrane trafficking between organelles via their GTP 
binding/hydrolysis cycle and they oscillate between GTP- and GDP-bound 
conformations. The GTP-bound form is considered the active form that interacts with 
downstream effector proteins. The most important feature of GTPases, however, is 
their ability to cycle between GTP- and GDP-bound states under the regulation of 
other factors. This cycle imposes the temporal and spatial regulation of membrane 
transport by Rab proteins, depending on the rates of nucleotide hydrolysis and 
exchange (reviewd by Zerial and McBride, 2001). A GDP/GTP exchange factor 
(GEF) in the Rab GTPase cycle catalyses nucleotide exchange from the GDP- to the 
GTP-bound state. Alternatively, the GTPase activating protein (GAP) facilitates GTP 
hydrolysis from the GTP- to the GDP-bound form (Fig.5). Changing the nucleotide 
bound to Rab also changes the conformation of the protein. Rab GTPases can 
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associate with membranes using their prenylated carboxyl termini. This post-
translational modification at the carboxyl terminus requires the initial recognition of a 
newly synthesised Rab protein by a Rab escort protein (REP). REP presents the Rab 
to a geranylgeranyl transferase that catalyses the modification with a 20-carbon 
geranylgeranyl prenyl chain. Rab proteins are membrane associated in their GTP 
bound form. After GTP hydrolysis, Rab proteins are released from the membrane by 
Rab GDP-dissociation inhibitor (GDI). GDI retrieves GDP-bound Rab from the 
membrane and allows for several rounds of the Rab GTP/GDP cycle, and for 
membrane association of the Rab protein (reviewed by Stenmark and Olkkonen, 
2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. The GTPase cycle of a Rab protein. The newly synthesised Rab is bound by Rab escort 
protein (REP), which introduces it to the Rab geranylgeranyl transferase (GGT). This enzyme attaches 
prenyl tails to C-terminal cysteine residues of Rab, enabling Rab protein to attach to membranes. When 
the Rab protein associates with a membrane, bound GDP is exchanged for GTP by a guanine 
nucleotide exchange factor (GEF). The GTP bound form of Rab binds to its effector proteins on 
membranes.  GTPase activating protein (GAP) catalyses GTP hydrolysis and Rab-GDP is released as a 
complex with GDP dissociation inhibitor (GDI) to the cytosol, where it can be recycled back to 
membranes. 
 
 
GEF
GAP
Pi
 20
3.1.2 Diversity in the functions and effectors of Rab proteins  
 
Several studies show that Rab proteins function throughout various steps of 
membrane trafficking: cargo selection, vesicle budding, tethering/docking that leads 
to membrane fusion. For example, Rab5 has shown to be crucial for cargo selection at 
the plasma membrane formed vesicles (Seachrist et al., 2002) and S. cerevisiae Rab 
protein Ypt1p is participating in the tethering step (Jones et al., 1995). These findings 
suggest that the same regulatory machinery may coordinate all steps in vesicle 
transport. Rab proteins are known to be highly specific regulators at distinct transport 
steps and this could explain the huge number of Rab proteins found in mammalian 
cells.  
Rab proteins interact also with cytoskeletal elements. They can associate with 
both microtubule- and actin-based motor proteins. A well-studied example of a 
cytoskeletally associated Rab protein is Rab27a, which is functionally connected to 
the actin based motor protein MyosinVa of melanosomes. The first indication of this 
association came from patients with Griscelli syndrome. Griscelli syndrome is a rare 
autosomal recessive disorder that is characterised by defective pigmentation of the 
skin and hair due to an aberrant accumulation of melanosomes in melanocytes, caused 
by mutations in MyosinVa. A novel and interesting finding was that some Griscelli 
patients had mutations in Rab27a causing the same defect in pigmentation as the 
mutations in MyosinVa. This finding indicates that Rab27a is closely associated with 
the motor protein MyosinVa (Menasche et al., 2000). In retinal pigment epithelial 
cells, Rab27a forms a complex with myosin-VIIA via a protein called MyRIP (El-
Amraoui et al., 2002). MyRIP was found to have a broad distribution at the tissue 
level and recent studies in pheochromocytoma (PC12) cells show that Rab27a and 
MyRIP bridge the secretory granules with F-actin and regulate the movement of 
vesicles within the actin cortex (Desnos et al., 2003). Rab6 in the Golgi interacts with 
another type of motor protein, the kinesin like protein Rabkinesin-6 (Echard et al., 
1998), involved in retrograde vesicular traffic between the Golgi and the ER (White et 
al., 1999). In addition, Rab8, which has an important role in polarised trafficking, 
shows association with microtubular elements. Overexpression of Rab8 results in the 
reorganisation of both actin filaments and microtubules (Peränen et al., 1996).  
Proteins that interact with the GTP bound form of Rabs, and mediate the 
downstream functional effects of Rabs, are called Rab effectors. In addition to the 
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function of Rab proteins, these effector proteins also show broad heterogeneity. Many 
of these proteins are docking/tethering factors, which together with Rab proteins, 
direct vesicles to the correct target membrane. The identification of Rab interacting 
proteins has revealed a vast complexity of machinery downstream of the early 
endosomal GTPase Rab5. Rab5 is a key factor in homotypic endosome-endosome 
fusion and it participates in clathrin dependent transport from the plasma membrane to 
early endosomes. More than 20 polypeptides from bovine brain cytosol that interact 
directly or indirectly with Rab5 have been found using an affinity–chromatography 
method and few of them have been characterised (Christoforidis et al., 1999a) (Table 
I).  
Table I. Rab5 effectors 
EFFECTOR DESCRIPTION 
APPL1 and 2 Cell proliferation regulators 
EEA1  FYVE-finger protein, tethering factor 
Rabaptin-5 Coiled coil protein with several interaction partners 
Rabenosyn 5 FYVE-finger protein, tethering factor 
Rabip4’ FYVE-finger protein, tethering factor 
p85?-p110? PI(3) kinase 
p150-hVPS34 PI(3) kinase 
 
Rabaptin-5 was the first identified Rab5 effector protein (Stenmark et al., 1995) that 
forms a complex with another protein called Rabex-5. Rabex-5 displays GDP/GTP 
exchange activity (Horiuchi et al., 1997). This complex also contains NSF, a factor 
responsible for SNARE complex disassembly (McBride et al., 1999). Rab5 is found 
to interact directly with two distinct PI(3)Ks, p85?-p110? and p150-hVPS34. p150-
hVPS34 has a function in vesicle formation in the Golgi and p85?-p110? may be 
involved in the formation of clathrin coated vesicles at the plasma membrane 
(Christoforidis et al., 1999b). In addition to the earlier mentioned EEA1, Rabenosyn 5 
is another FYVE finger effector of Rab5. It acts in a way similar to EEA1. Rabenosyn 
5 is recruited in a Rab5 and PI(3)P dependent fashion to early endosomes where it 
works in the docking and fusion process (Nielsen et al., 2000). The latest interesting 
finding is that Rab5 binds also nuclear proteins APPL1 and APPL2. APPLs are 
essential factors for cell proliferation and are located in endosomal structures from 
which they are relocated to the nucleus upon stimulus. This finding indicates a direct 
link between the plasma membrane signalling, endosomes and nucleus. The 
trafficking through endosomes may have more a prominent role in nuclear signal 
transduction than previously thought (Miaczynska et al., 2004). Rab5 also interacts 
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with angiotensin II Type 1A receptor (AT1AR) at the plasma membrane, and ligand 
activation of the receptor is suggested to affect Rab5 function and thereby the 
endocytosis process (Seachrist et al., 2002).  
Several studies have reported direct molecular links between Rab effector 
proteins and the SNARE machinery or with the SM protein family. For example, 
EEA1 binds directly to the t-SNARE proteins Syntaxin 6 and 13 (McBride et al., 
1999; Simonsen et al., 1999), and the EEA1-like protein in yeast, Vac1p, interacts 
with both the Rab GTPase Vps21p and the SM protein Vps45p (Tall et al., 1999). In 
mammalian cells, the pancreatic ?-cell protein granuphilin interacts with both the 
GTP bound form of Rab3 and the SM protein Munc18a. Granuphilin is a member of 
the synaptotagmin-like (Slp) protein family and is associated with insulin-containing 
secretory granules. Granuphilin, like other Slp proteins, has C2-calcium-phospholipid 
binding domains with a Ca2+ sensor function. In addition, it shares structural 
similarities with other Rab effectors, such as a Zn2+-finger motif involved in Rab 
binding (Coppola et al., 2002).  More of these links and more effector proteins and 
their oligomeric complexes have to be found to understand in detail the function of 
Rab proteins in the regulation of membrane trafficking. 
 
3.1.3 Endosomal Rab proteins 
 
A strikingly high number of Rab GTPases have been localised to endosomal 
membrane compartments (Table II). This most probably reflects the complex 
organisation and multiple sorting functions of endosomes. Material internalised from 
the cell surface firstly enters early endosomes, which are responsible for the 
dissociation and sorting of receptors and ligands in the slightly acidic environment. 
Many receptors are recycled back to the cell surface. Molecules destined for 
degradation are sorted and move through the late endosomes to lysosomes. Late 
endosomes also receive cargo from the TGN network through the mannose-6-
phosphate receptor (M6PR) pathway. The M6PR recognises lysosomal proteins in the 
TGN and transports these cargo proteins to late endosomes. At the low pH of late 
endosomes, the cargo dissociates from the M6PR and the receptors are transported 
back to the Golgi for further rounds of transport. All endosomal organelles are widely 
distributed in cells and they typically consist of vacuolar-shaped and tubular 
microdomains (reviewed by Deneka and van der Sluijs, 2002). 
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Table II. Endosomal Rab proteins in mammalian cells 
NAME LOCALISATION ROLE EFFECTORS 
Rab4 Early/recycling 
endosomes 
Sorting/recycling in early 
endosomes 
Rababtin-5/5? 
Rabaptin-4 
Rab5 Early endosomes, 
plasma membrane, 
clathrin-coated 
vesicles 
Clathrin coated vesicle/early 
endosome fusion, homotypic fusion 
of early endosomes, ligand 
sequestration at plasma membrane 
See Table I 
Rab7 Late endosomes Early-late endosome trafficking, 
lysosome biogenesis 
RILP, RabRING7, 
p150-hVPS34 
Rab9 Late endosomes Late endosome-Golgi trafficking TIP47 
Rab11 Early/recycling 
endosomes 
Recycling through perinuclear 
endosomes 
Rab11BP 
Rab15 Early endosomes Early endosome-plasma membrane 
trafficking 
N.D. 
Rab18 Early endosomes Apical endocytosis/recycling N.D. 
Rab20 Early endosomes Apical endocytosis/recycling N.D. 
Rab22 Early endosomes N.D. N.D. 
Rab23 Early endosomes/ 
plasma membrane 
Negative regulator of sonic 
hedgehog signaling pathway 
N.D. 
N.D., Not determined 
 
The previously mentioned Rab5 is the most thoroughly characterised early 
endosomal Rab protein (Novick and Zerial, 1997). In addition, Rab4 and Rab11, 
located on early and recycling endosomes, are also well-studied. These proteins are 
responsible for the endocytic recycling process. Rab4 is suggested to act at the level 
of early ‘sorting’ endosomes (van der Sluijs et al., 1992), whereas Rab11 exerts a 
function in trafficking of cargo through the perinuclear recycling endosomes (Ullrich 
et al., 1996). These three Rab proteins have distinct but partly overlapping 
distributions, forming domains at the surface of endosomes. The group of Zerial 
showed with fluorescently tagged Rab proteins and fluorescently labelled transferrin 
(as a cargo) how different Rab proteins label distinct domains on the same endosomes 
and how the cargo travels through these domains. Three major populations of domains 
were observed: one that contains only Rab5, a second containing Rab5 and Rab4, and 
a third one containing Rab4 and Rab11. The distinct nature of these domains is 
reflected by their differential sensitivity to pharmacological tools, such as brefeldin A 
(causes Golgi complex disruption) and wortmannin (PI(3)K inhibitor). Transferrin 
seems to enter the endosomal system via a Rab5 domain and returns to the surface via 
Rab4/Rab11 domains (Sonnichsen et al., 2000). It is known that some of the effector 
proteins can interact with two different Rab proteins. Rabaptin-5 is a bifunctional 
effector of Rab5 and Rab4 (Vitale et al., 1998) and the Rab5 effector Rabenosyn 5 
also binds directly to Rab4 (Nielsen et al., 2000). Neither of these effector proteins 
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binds to Rab11. Rabip4 binds simultaneously to the GTP-form of both Rab4 and Rab5 
(Fouraux et al., 2003). It has been suggested that the bifunctional effector proteins 
participate in communication between different Rab domains and serve as platforms 
for domain formation (reviewed by Deneka and van der Sluijs, 2002). Several other 
not so thoroughly characterised Rab proteins are located to early endosomes, like 
Rab15, Rab18, Rab20, Rab22 and Rab23 (Eggenschwiler et al., 2001; Evans et al., 
2003; Lutcke et al., 1994; Olkkonen et al., 1993; Zuk and Elferink, 1999). 
Late endosomes are characterised by their low lumenal pH (lower than in early 
endosomes) and extensive internal membranes rich in the unique phospholipid species 
lyso-bis-phosphatidic acid (LBPA). Rab9 is a late endosomal protein that regulates 
trafficking between late endosomes and the TGN (Lombardi et al., 1993). It has been 
shown by video microscopy that Rab9-positive vesicles move along microtubules and 
fuse with the TGN (Barbero et al., 2002). The Rab9 effector protein, Tail Interacting 
Protein of 47 kD (TIP47), mediates M6PR recycling from late endosomes to the 
Golgi. TIP47 binds directly to M6PR and Rab9 (Carroll et al., 2001). Also, Rab7 is 
localised to late endosomes but in domains separate from Rab9 domains (Barbero et 
al., 2002). Data has been presented for its function in trafficking from early to late 
endosomes (Feng et al., 1995) and/or in the biogenesis of lysosomes (Meresse et al., 
1995). Rab7 overexpression causes several lysosomal defects while early endosomal 
compartments remain unchanged (Bucci et al., 2000). Rab7-Interacting Lysosomal 
Protein (RILP) is a Rab7 effector which recruits dynein-dynactin motor complexes to 
Rab7-containing late endosomes and lysosomes (Jordens et al., 2001). Another Rab7 
effector is RabRING7, a cytosolic protein that is recruited to late endosomal and 
lysosomal membranes by the GTP bound form of Rab7 (Mizuno et al., 2003). Rab7 
was also shown to bind to PI(3)kinase, p150-hVPS34, that links Rab7 to signaling 
pathways (Stein et al., 2003). 
 
3.2 Sec1/Munc18 (SM) related protein family 
 
3.2.1 Members of the SM protein family 
 
Sec1/Munc-18 (SM) genes were first discovered from screens for membrane 
trafficking mutants in Caenorhabditis elegans and Saccharomyces cerevisiae (Aalto 
et al., 1992; Brenner, 1974; Novick and Schekman, 1979). There are four SM proteins 
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in yeast and seven in mammals (see Table III). They are all 60-70 kDa hydrophilic 
proteins devoid of transmembrane segments. SM related proteins are highly 
conserved among species and most of them share the common feature of binding t-
SNARE proteins of the syntaxin family with high affinity (reviewed by Toonen and 
Verhage, 2003). 
 
Table III. Main characteristics of the SM proteins in different organisms 
 
SPECIES 
 
 
SM PROTEIN SYNTAXIN 
INTERACTIONS 
SYNTAXIN 
BINDING 
MODEa 
PROPOSED FUNCTION 
S. cerevisiae Sec1p Sso1p, Sso2p Core 
complex 
Vesicular transport to 
plasma membrane 
 Sly1p Sed5p, Ufe1p N-terminus ER to Golgi transport 
 Vps33p Vam3p Indirect Endosome and vacuole 
membrane trafficking 
 Vps45p Tgl2p, Pep12p N-terminus Golgi to late 
endosome/vacuole 
transport 
D. 
melanogaster 
ROP Syntaxin N.D.b Synaptic vesicle release 
and general secretion 
 Sly1 N.D. N.D. N.D. 
 Vps45 N.D. N.D. N.D. 
 Vps33/carnation N.D. N.D. Transport to lysosomes 
and pigment granules 
C. elegans UNC-18 Syntaxin (UNC-
64)  
Closed 
conform. 
Synaptic vesicle release  
 5 other genes in 
G.D.c 
N.D. N.D. N.D. 
Mammals Munc18a Syntaxin-1,-2,-3 Closed 
conform. 
Synaptic vesicle release, 
chromaffin granule 
exocytosis 
 Munc18b Syntaxin-1,-2,-3 N.D. Apical trafficking in 
epithelial cells, mast cell 
granule secretion 
 Munc18c Syntaxin-2,-4 N.D. GLUT4 translocation, 
platelet granule exocytosis 
 mVPS45 Syntaxin-4,-6,-13,-
16 
N-terminus N.D. 
 mVPS33A&B N.D. N.D. N.D. 
 mSly1 Syntaxin-5,-18 N.D. ER to Golgi transport 
a The binding modes are illustrated in Fig.7; closed conformation,A; core complex,B; N-terminal,C; Indirect 
interaction,D;   b N.D., Not determined;    
c
 G.D., Genome database (www.wormbase.org) 
 
 SM related proteins are also highly specific in their activity. Proteins that act in the 
same pathway are able to rescue a null mutation in a different species but not in 
different pathways in the same species. For instance, murine Munc18a rescues the C. 
elegans Munc-18 null mutant phenotype, but Munc18c does not (Gengyo-Ando et al., 
1996). X-ray crystallographic structural information on SM proteins is available from 
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three species: from a complex formed between the rat nervous system SM protein 
Munc18a and the cytosolic domain of syntaxin 1A (Misura et al., 2000) from the S. 
cerevisiae SM protein Sly1p complexed with a short N-terminal peptide of the yeast 
syntaxin Sed5p (Bracher and Weissenhorn, 2002), and from uncomplexed squid 
neuronal Sec1p (Bracher et al., 2000). All three structures (free or complexed) reveal 
a similar arch-shaped organisation composed of three domains 1, 2 and 3. Domain 3 
in the mammalian Munc18a has been further divided into domains 3a and b. The 
syntaxin binding site is located between domains 1 and 3a (Misura et al., 2000) 
(Fig.6).  
 
Figure 6. Structure of Munc18a and syntaxin 1a. A. A schematic presentation of Munc18a topology. 
Domain 1 is shown in blue, domain 2 in green and domain 3 in yellow. Helices are shown as cylinders 
and ?-strands as arrows. Asterisks indicate breaks in the structure. Dashed lines denote domains 3a and 
3b. B. A ribbon representation of Munc18a. Coloured as in A. C. Topology diagram of syntaxin 1a. 
The Habc domain is shown in red, the linker region in orange and the H3 region in purple. D. A ribbon 
representation of syntaxin 1a, with the same colour coding as in C. The conformations are as they 
appear in the complex, but the two proteins have been separated for clarity. Syntaxin 1a is in the 
complex located in the cleft between Munc18a domains 1 and 3a (reproduced with permission from 
Misura et al. 2000; http://www.nature.com/). 
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3.2.2 Different binding modes of SM proteins 
 
Even though the structure of SM related proteins is conserved they bind syntaxins in 
very different ways. Four different binding modes can be distinguished (Fig.7).  
 
Figure 7.  The different modes of interaction between SM proteins and syntaxins. A. Binding to a 
monomeric syntaxin in a closed conformation (Munc18a-syntaxin 1A complex). B. Binding to a 
SNARE complex without affinity for monomeric syntaxin (Interaction of the S. cerevisiae  Sec1p with 
a complex of Ssop, Sncp, and Sec9p). C. Binding to an N-terminal peptide motif of syntaxin (Sly1p 
and Vps45p interactions with Sed5p and Tlg2p, respectively). This binding mode allows association 
with syntaxin, both in a monomeric form and within SNARE complexes. D. Indirect association with 
syntaxin mediated by protein complexes (Binding of Vps33p to Vam3p). Though not graphically 
depicted in the images, the syntaxin binding surface on SM proteins may vary for the different binding 
modes.  
 
Most of the syntaxins can adopt two conformations,open and closed. In the closed 
conformation, the N-terminal domain (Habc domain) folds back onto the SNARE 
motif, preventing the syntaxin from forming complexes with its partner SNAREs. 
This structure is required for mammalian Munc18a binding (Dulubova et al., 1999; 
Misura et al., 2000). Contrary, yeast Sec1p binds only assembled SNARE complexes 
(Carr et al., 1999). The third binding mode is independent of the syntaxin 
conformation. The SM proteins involved in Golgi membrane trafficking (both in yeast 
and mammals), Sly1p/mSly1 and Vps45p/mVPS45, bind a very N-terminal motif of 
their respective syntaxins. This motif is not present in all syntaxins (Dulubova et al., 
2002; Yamaguchi et al., 2002). The fourth binding mode involves binding via protein 
complexes. A yeast SM protein Vps33p is part of a complex, called the HOPS 
complex, that functions in Golgi-to-vacuole transport and interacts with the syntaxin 
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homologue Vam3p (Seals et al., 2000). Similar complexes are also observed in 
Drosophila (Sevrioukov et al., 1999).  
 
3.2.3 Functions of SM proteins 
 
The original idea was that SM proteins act as negative regulators of SNARE complex 
formation (Pevsner et al., 1994; Schulze et al., 1994).  Most of the overexpression 
studies indicate that SM proteins inhibit vesicle transport at some step before fusion. 
For example, mammalian Munc18c prevents GLUT4 vesicle fusion in adipocytes 
(Thurmond et al., 1998) and in the Munc18c transgenic mouse model insulin secretion 
is inhibited (Spurlin et al., 2003). In Drosophila, overexpression of ROP inhibits 
neuro transmission in a dose-dependent fashion (Schulze et al., 1994; Wu et al., 1998) 
and microinjection of the squid SM protein s-Sec1 into giant squid axons was reported 
to inhibit evoked neurotransmitter release (Dresbach et al., 1998). In addition, a 
number of peptide overexpression studies support the idea of an inhibitory role of SM 
proteins. Expression of Munc18b, its domain 3, or a specific ‘effector loop’ included 
in domain 3 were reported to inhibit the IgE-triggered exocytosis of mast cell granules 
(Martin-Verdeaux et al., 2003) In adipocytes, overexpression of Munc18c or 
microinjection of a Munc18c ‘effector loop’ peptide inhibited GLUT4 translocation to 
the plasma membrane (Tamori et al., 1998; Thurmond et al., 1998; Thurmond et al., 
2000). Moreover, corresponding peptides derived from either Munc18a or Munc18c 
were recently found to inhibit granule exocytosis in permeabilised human platelets 
(Schraw et al., 2003).  
There are some exceptions among the results showing that the role of SM 
proteins is inhibitory. In cell lines derived from adrenal chromaffin cells, 
overexpressed Munc18a has no effect on secretion (Graham et al., 1997), and 
overexpression of Munc18a in primary chromaffin cells and motor neurons enhances 
fusion of vesicles (Voets et al., 2001). Also in platelets Munc18c peptides 
corresponding to a syntaxin 4 binding region were found to enhance Ca2+- dependent 
granule exocytosis (Houng et al., 2003). The discrepancy from overexpression data 
can be explained by the specialisation of each of the Munc18 proteins to distinct 
trafficking steps in mammalian cells and the fact that the primary target of the 
peptides used by Houng et al. 2003 was different than in previous peptide studies. All 
of the effects caused by SM proteins are consistent with the idea that the ratio between 
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SM proteins and their cognate syntaxins is crucial for normal membrane trafficking 
and that an excess amount of SM proteins can lead to inhibition of a specific transport 
step. Further evidence that the dose of SM proteins is crucial for syntaxin function is 
that the inhibitory effect of ROP overexpression in Drosophila is overcome by 
simultaneous expression of syntaxin (Wu et al., 1998), and similarly, co-injection of 
an N-terminal cytosolic fragment of syntaxin into squid giant axons, together with s-
Sec1, abolishes the inhibitory effect of s-Sec1 (Dresbach et al., 1998). In addition, 
syntaxin1A levels are reduced in null-mutant mice (Toonen and Verhage, 2003), and 
Munc18c protein levels are significantly lower in mice heterozygous for a null allele 
of the cognate t-SNARE syntaxin 4 (Yang et al., 2001). 
SM gene disruption causes severe trafficking defects. In S. cerevisiae, four SM 
related proteins all work in different trafficking steps: between Golgi and plasma 
membrane (Sec1p), ER and Golgi (Sly1p), Golgi and the prevacuolar compartment 
(Vps45p) or the prevacuolar compartment and vacuoles (Vps33p). Disruption of these 
genes causes an accumulation of transport vesicles in the respective trafficking steps 
that they regulate (Cowles et al., 1994; Ossig et al., 1991; Robinson et al., 1988; Wada 
et al., 1990). Munc18a null-mutant mice are alive until birth. The gene deletion allows 
for an apparently normal brain assembly and the synapses develop normally yet the 
brains are synaptically silent. After assembly is completed, neurons undergo apoptosis 
even though the normal Munc18b and c genes are present (Verhage et al., 2000). This 
observation is quite remarkable considering the fact that Munc18a and Munc18b show 
the same syntaxin specificity.  
 Several studies suggest that SM proteins are involved in the final steps before 
fusion yet the biochemical approaches taken thus far are insufficient to understand the 
exact mechanism. Their characteristic binding to syntaxins indicates a role in SNARE 
complex modulation, or possibly in the regulation of syntaxin levels. However, high 
affinity to syntaxins is not necessarily the only or main functionally relevant feature of 
SM proteins. (reviewed by Toonen and Verhage, 2003).  As shown by the effector 
loop peptide studies, there are other important regulatory elements in SM proteins. 
One key regulatory mechanism is phosphorylation. PKC stimulates Ca2+-dependent 
exocytosis in various secretory cell types and it phosphorylates Munc18a in a cell free 
system. This phosphorylation inhibits Munc18a from interacting with syntaxin 1A, 
yet PKC does not phosphorylate the assembled Munc18a-syntaxin complex (Fujita et 
al., 1996) nor does it cause disassembly of the complex. Munc18a is also 
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phosphorylated by Cdk5. Unlike PKC, Cdk5 seems to be able to phosphorylate 
Munc18a in a preformed Munc18b-syntaxin heterodimer, resulting in disassembly of 
the complex (Fletcher et al., 1999).   
 
3.2.4 Interactions of the SM protein family with other components of the vesicle 
transport machinery 
 
Syntaxins are not the only binding partners of SM proteins. Mammalian Munc18a 
also interacts with two other families of membrane bound proteins, Doc2 and Munc18 
interacting proteins (the Mint proteins). There are three members of the Mint family. 
Mint1 and -2 are brain specific whereas Mint3 is ubiquitously expressed. Mint 
proteins have phosphotyrosine binding domains (PTB) at their C-terminal ends that 
bind specifically phosphatidylinositol phosphates (PIPs). Munc18a binds the N-
terminal part of Mint1 and -2, however, as the N-terminal part is missing from Mint3  
this protein is unable to bind Munc18a (or Munc18b) (Okamoto and Südhof, 1998). 
Interestingly, the Mint proteins were reported to regulate trafficking of the Alzheimer 
disease related amyloid precursor protein, ?-APP (Hill et al., 2003).  
Syntaxins and Doc2 proteins compete for Munc18a binding. The Doc2 family 
has two members, the neuronal Doc2A and the ubiquitously expressed Doc2B. They 
are enriched on synaptic vesicles and contain a double C2 domain capable of binding 
Ca2+ and phospholipids. Doc2 proteins have a role in Ca2+-evoked neurotransmitter 
release and the entire amino acid sequence of Munc18a is needed for the interaction 
with Doc2 family members (Verhage et al., 1997).  
 The pancreatic ?-cell protein granuphilin interacts with the GTP bound form 
of both Rab3 and Munc18a. Granuphilin is a member of the synaptotagmin-like (Slp) 
protein family and is associated with insulin-containing secretory granules. 
Granuphilin, like other Slp proteins, has C2-calcium-phospholipid binding domains 
with a Ca2+ sensor function. In addition, it shares structural similarities with other Rab 
effectors, such as a Zn2+-finger motif involved in Rab binding (Coppola et al., 2002). 
There is also evidence that SM proteins interact with the cytoskeleton. Munc18b 
shows a microtubule-dependent localisation and is redistributed after disruption of the 
microtubule network in mast cells. Together with the microtubule network, Munc18b 
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seems to have an important role in the regulation of secretory granule exocytosis in 
this cell type (Martin-Verdeaux et al., 2003). 
S. cerevisiae genetic studies of Sec1p have revealed several indirect 
interaction partners. Overexpression of SEC1 suppresses defects in most of the 
exocyst mutants  (Aalto et al., 1993; Brummer et al., 2001). A physical interaction has 
only been documented between Sec1p and a small hydrophilic protein Mso1p. The 
loss of MSO1 causes an accumulation of secretory vesicles in the yeast bud (Aalto et 
al., 1997). So far no mammalian homologues for Mso1 have been characterised. Yeast 
genetic studies have often led to the identification of SM protein interactions with 
tethering complexes. Also, in this case loss of MSO1 results in synthetic interactions 
between most of the genes that encode components of the exocyst complex regulated 
by the Rab GTPase Sec4p (Guo et al., 1999; TerBush et al., 1996). No direct 
interaction partners have been identified for Sly1p (a Sec1 homologue involved in ER 
to Golgi transport) except from genetic studies where interactions with tethering 
complexes and a Rab protein, Ypt1p have been shown (Dascher et al., 1991; 
Sapperstein et al., 1996).  The S.cerevisiae Vps33p is a component of a hetero-
oligomeric protein complex containing the class-C Vps proteins. Mutations in class-C 
VPS genes result in severe defects of vacuolar protein sorting and morphology. The 
hetero-oligomeric complex consists of four proteins, Vps11p, Vps16p, Vps18p and 
Vps33p that interact genetically and physically (Rieder and Emr, 1997), and associate 
with the vacuolar syntaxin homologue Vam3p (Sato et al., 2000). Vsp45p associates 
directly with Vac1p, which is an EEA1-like zinc-binding FYVE finger protein and 
regulates trafficking between the Golgi and endosomes. Vac1p also associates with 
the Rab GTPase Vsp21p, thus forming a physical connection between a Rab and an 
SM protein (Peterson et al., 1999; Tall et al., 1999). 
 An SM protein in Caenorhabditis elegans, UNC-18, interacts directly with the 
priming factor UNC-13 in vitro. UNC-13 also binds to the N-terminal part of syntaxin 
(only the open conformation of syntaxin) and can displace UNC-18 from the syntaxin 
complex (Sassa et al., 1999). However, an interaction between the mammalian 
homologues of these proteins, Munc18 and Munc13, has not been shown. Munc13-1 
in mammalian cells associates with Doc2A and also with syntaxin (Mochida et al., 
1998). 
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3.3 Other regulatory proteins   
 
The neurotransmitter exocytosis in neurons requires a highly regulated membrane 
fusion event. A unique feature of synaptic transmission is the tight coupling between 
the increase in intracellular Ca2+, produced by the arrival of a nerve impulse, and the 
activation of the exocytotic synaptic fusion machinery. Studies on the synaptic fusion 
machinery have led to the identification of a number of SNARE complex regulators 
such as synaptotagmin, GATE-16, LMA1, synaptophysin, tomosyn, amisyn, Vsm1 
and complexins. Several of these are also expressed in non-neuronal tissues. These 
regulators bind directly to the SNARE proteins and regulate SNARE complex 
assembly. (reviewed by Gerst, 2003). Synaptotagmins are suggested to be calcium 
sensors that modulate secretion. The synaptotagmin protein family is a large family 
found exclusively in higher eukaryotes. They localise on membranes and include two 
Ca2+ binding C2 domains. Synaptotagmins bind directly to SNAREs in a Ca2+ 
dependent manner (Earles et al., 2001). Synaptotagmin-like proteins are also 
expressed in non-neuronal tissues. The earlier mentioned granuphilin is a 
synaptotagmin-like protein that is expressed in ?-cells and the pituitary gland where it 
controls exocytosis. Interestingly, granuphilin binds both Munc18a and Rab3 but does 
not bind SNARE proteins (Coppola et al., 2002).  
Tomosyn is a regulator of SNARE complexes. It is abundant in the brain 
where it forms a complex with Syntaxin 1A and SNAP-25 and is capable of 
dissociating Munc18a from the complex with syntaxin 1A (Fujita et al., 1998). A 
recent study from adipocytes showed that Munc18c binds the Syntaxin4/tomosyn 
complex, suggesting that tomosyn and Munc18c operate at a similar stage during the 
Syntaxin 4 SNARE complex assembly cycle, perhaps by a different mechanism than 
Munc18a and tomosyn in neurons (Widberg et al., 2003). 
If SM proteins are regulating the SNARE complex through their ability to bind 
to the t-SNARE proteins, syntaxins, one could expect that there are specific v-SNARE 
regulators as well. Indeed, synaptophysins are shown to interact with v-SNARE 
proteins (VAMP-like proteins) and prevent their participation in SNARE complex 
formation (Calakos and Scheller, 1994). 
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4. Vesicle trafficking in polarised cells 
 
Cell polarity is a reflection of complex mechanisms that establish and maintain 
functionally specialised domains of different lipid and protein compositions in the 
plasma membrane and cytoplasm. Polarity is fundamental to the development and 
functioning of all organisms from bacteria to humans and has been studied in the 
context of cell differentiation, signalling, cytoskeletal organisation and cell division.  
Polarisation of epithelial cells is a complex process directed by cell-cell and 
cell-extracellular matrix interactions. Epithelial cells form a tight layer whereby the 
outside edges of the cells cover all free open surfaces of the body, including the skin 
and mucous membranes that communicate externally of the body. The plasma 
membrane of an epithelial cell is divided into apical and basolateral domains and three 
major trafficking pathways help maintain the polarity. Firstly, newly synthesised 
proteins are transported through the Golgi complex to the TGN where they are sorted 
to apical or basolateral surfaces. Some proteins are transported to endosomes and only 
then to the cell surface. Secondly, some proteins are selectively retained at the cell 
surface and thirdly, components that are not retained at the surface are rapidly 
endocytosed to endosomes. From endosomes, proteins can be recycled back to the cell 
surface, delivered to late endosomes or transported across the cell to the opposite 
surface. This last process is called transcytosis (reviewed by Mostov et al., 2003). 
Examples of cells in which polarised trafficking has been studied include those from 
intestine (Caco-2 cells, human) and kidney (MDCK, canine and LLC-PK1, porcine), 
pancreatic acinar cells, and liver hepatocytes. In neurons, the cell surface is divided 
into axonal and somatodendritic domains which correspond in some aspects to the 
apical and basolateral membrane domains of epithelial cells (reviewed by Nelson and 
Yeaman, 2001). Defects in trafficking pathways that maintain epithelial polarity can 
cause disease in organs in which epithelial cell polarity is crucial, for example the 
liver, kidney and intestine (Stein et al., 2002). Finally yeast cells display polarity 
during budding and mating (reviewed by Chant, 1994). 
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II AIMS OF THE STUDY 
 
Vesicular transport is one of the most intensively studied research areas in cell 
biology. By identifying the molecular mechanisms behind the transport reseachers 
will hopefully uncover the mystery of how cells sort and transport huge amounts of 
protein and lipid to correct destinations. Hundreds of proteins constitute the vesicle 
transport machinery, and to elucidate the function of one single protein or to find a 
new binding partner, will provide us with the important pieces of the puzzle. One of 
the primary machineries required for membrane trafficking is the SNARE complex. 
SNARE proteins are located on various cell organelles and mediate vesicle fusion to 
the target membrane. There are two main regulatory families for SNARE proteins: the 
Rab protein family and the Sec1/Munc18 (SM) protein family. The Rab protein 
family, which consists of more than 60 members in humans, regulates membrane 
trafficking through GTPase activity, and each of these proteins is specialised for one 
trafficking step. The SM family members are more general modulators of SNARE 
complex assembly yet their exact function remains unsolved. In the present study the 
aims below were set to identify the function of a small GTPase, Rab22a, and a 
member of the SM family, Munc18b.  
 
The specific aims of the study were: 
 
I  To characterise the basic properties of Rab22a, in particular, the sub-cellular 
localisation of Rab22a and its role in endocytic events. 
 
II  To gain knowledge on the function of Munc18b by site-directed mutagenesis. 
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III METHODS 
 
 
1. List of published methods 
 
All of the published methods used in this thesis are summarised in Table IV below. 
Further details concerning these methods can be found in the original publications. 
 
Table IV. Published methods used in this thesis  
METHOD ORIGINAL PUBLICATION 
General DNA techniques I, II, III 
Cell culture I, II, III 
SDS-PAGE and Western blotting I, II, III 
Immunofluorescence microscopy I, III 
Generation of recombinant SFVs and viral infection I, II, III 
Yeast two-hybrid analysis I 
Protein expression in E. coli I 
In vitro assay for Munc18b-syntaxin binding I, II, III 
Analysis of transferrin endocytosis I 
Analysis of EGF uptake and degradation I 
TRITC-dextran uptake I 
Analysis of intracellular trafficking of AGA I 
Site directed mutagenesis II, III 
In vitro translation II, III 
Phosphorimager quantitation II 
Metabolic labelling of proteins II, III 
Immunoprecipitation II, III 
Surface immunoprecipitation II 
Cell fractionation by flotation sucrose gradients II 
Protein expression in insect cells II 
Protein purification using Ni-NTA-agarose II 
Transfection of mammalian cells I, III 
HA trafficking assay by confocal microscopy III 
Generation of a homology model for the Munc18b/syntaxin3 
complex III 
 
 
2. Unpublished methods 
 
2.1 Transferrin endocytosis and recycling in COS-1 cells 
 
African green monkey kidney (COS-1) cells were plated into 1 cm diameter wells and 
transfected with Rab22a pcDNA3.1 constructs (wt, mutants or empty vector as a 
control), together with a human transferrin receptor (tfR) cDNA for 24 h. FUGENE 6 
(Roche) transfection reagent was used according to the manufacturer’s instructions. 
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The cells were washed twice with phosphate-buffered saline (PBS) and incubated at 
+37°C for 1 h in Dulbecco’s modified Eagle medium containing 0.1% BSA 
(DMEMB). The cells were transferred onto ice and 2 µg/ml biotin-holo-transferrin 
(Sigma) in DMEM was allowed to bind for 1 h. Following this, unbound biotin-
transferrin was removed by extensive washing with ice cold DMEMB (four washes), 
and finally with PBS. The biotin-transferrin was endocytosed at +37°C in DMEMB 
and the cells were collected at various time points. After each time point, non-
endocytosed biotin-holo-tranferrin was washed away two times with ice-cold 
DMEMB + 200 µg/ml holo-transferrin (Sigma) (shaking on ice) and just before lysis, 
shortly with ice cold PBS. The cells were lysed in ST-buffer (1 mM EDTA, 50 mM 
NaCl, 0.1% SDS, 1% Triton X-100, 10 mM Tris-HCl pH 7.5) and the biotin-holo-
transferrin was measured from lysates with a solid phase assay. Immuno maxisorb 96-
well plates were coated overnight with 2 µg/ml anti-transferrin (Sigma) antibody in 50 
mM NaHCO3, pH 9.6, and blocked with 0.2% BSA/ ST buffer for 4 h at room 
temperature. The cell lysates were incubated on the 96-well plates overnight followed 
by two washes with PBS. The plate was blocked with 0.2% BSA/ ST-buffer for 5 min 
at room temperature and washed again two times with PBS. Streptavidin-HRP in 
0.2% BSA/ST-buffer (1:5000, Amersham) was added to the wells, incubated for 1 h 
at room temperature and then washed away with PBS. As a substrate, 0.5 mg/ml 1,2-
phenylendiamin (Merck) in 50 mM Na2HPO4, 30 mM citrate, pH 5 was used. Fresh 
substrate was prepared each time and 0.03% (final concentration) H2O2 was added to 
the substrate solution before adding to the wells. The reaction was stopped with 2N 
H2SO4 (¼ of the reaction volume) and the absorbance (A490) was measured. 
The recycling assay was carried out in a similar fashion. For this purpose, early 
endosomes were loaded with biotin-holo-transferrin at 17°C for 2 h. 
 
2.2 Generation of Adenoviruses  
 
Munc18b Adenoviruses were generated according to the Q-BIOgene AdenoVator 
System instructions. Munc18b wt, S48D, K314L/R315L and E59K cDNAs, with an 
N-terminal myc-tag, were inserted into the BglII site of pAdenoVator-CMV5-IRES-
GFP transfer vector. To create recombinant AdenoVator plasmids, the transfer vector 
constructs were linearised with PmeI and co-transformed with pAdEasy-1 (an 
adenoviral genome vector) into the competent E. coli cell line, BJ5183. Homologous 
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recombination of the vectors resulted in recombinant plasmids and the correctly 
recombined clones were confirmed using a restriction digestion with PacI. The 
recombinant AdenoVator plasmids were transfected into the 293A packaging cell line 
(human embryonic kidney cell line) and after one week cells were collected, 
resuspended in PBS and lysed using a freeze-thaw method. Cellular supernatants 
containing viral particles were used for the first infection of 293A cells. After five 
days, the cells were collected and lysed in a similar fashion as described previously 
and the supernatant was used for a second infection. The cells were infected three 
times to enrich the viral supernatant. Viral particles were then concentrated from a 
cesium gradient according to the manufacturer’s instructions. 
 
2.3 Amylase secretion in pancreatic acinar cells 
 
Pancreatic acinar cells were isolated from male Spraque-Dawley rats according to 
Gaisano et al., 1989.  Dispersed single acinar cells were plated on 12-well plates and 
infected with Munc18b adenoviruses for 12 h. The infected cells were stimulated for 
30 min with 100 pM OPE, a phenylethylester analogue of cholecystokinin (CCK), for 
secretion. The secreted amylase was measured from the medium using a colorometric 
assay (Huang et al., 2001). In this assay, ?-amylase catalyses the hydrolysis of 
internal ?-1,4-glycan links of polysaccharides containing 3 or more ?-1,4-linked D-
glucose units, yielding a mixture of maltose and glucose. One unit of enzyme liberates 
from starch (used as a substrate in this assay) 1 µmol of reducing groups (calculated 
as maltose) per minute at 25°C in pH 6.9.  
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IV RESULTS AND DISCUSSION 
 
 
1. Characterisation of the small GTPase Rab22a 
 
Rab22a cDNA, cloned from the canine epithelial cell line (MCDK II), was previously 
employed for mRNA expression studies. It was shown that Rab22a mRNA is 
expressed ubiquitously in mammalian tissues and that the protein localises to 
endosomal elements in baby hamster kidney (BHK-21) cells (Olkkonen et al., 1993).  
To study the localisation and function of Rab22a further, the wild-type (wt) protein 
and two mutant forms of Rab22a were cloned into mammalian expression vectors 
pcDNA3.1 and pGEM-1, both of which are compatible with the Vaccinia T7 
expression system. For Vaccinia expression, the cells were firstly infected with 
modified Ankara T7 polymerase recombinant Vaccinia virus, followed by transfection 
with pGEM-1 constructs (Sutter et al., 1995). Experiments were also carried out using 
recombinant Semliki Forest viruses (SFV). In the SFV system, the gene of interest is 
cloned into the viral vector under an SFV 26S promoter and viral particles are 
produced in BHK-21 cells (Liljestrom and Garoff, 1991). The mutant proteins with 
defects in the GTPase cycle of Rab22a were created according to the literature 
(Olkkonen and Stenmark, 1997). Rab22a S19N is equivalent to dominant inhibitory-
type mutants of other Rab-proteins and it is expected to show a lower affinity for GTP 
than for GDP. The Rab22a Q64L mutant represents an activated GTPase deficient 
mutant.  
 
1.1 Localisation of Rab22a 
 
Localisation of overexpressed Rab22a protein was studied by immunofluorescense 
microscopy. Rab22a was stained together with marker proteins.  Wt Rab22a formed 
large vesicular-like structures of various sizes. These structures co-localised with the 
early endosomal marker EEA1 (I, Fig.1 A,B,C), but not with the late 
endosomal/lysosomal markers lysosomal-associated membrane protein (LAMP-1) (I, 
Fig.1 D,E,F), and lyso-bis-phosphatidic acid (LBPA). In addition, Rab11, a marker of 
perinuclear recyling endosomes, did not overlap with Rab22a wt staining. The active 
mutant Q64L formed similar enlarged EEA1 positive endosomal structures to the wt 
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protein (I, Fig.1 J-L). In cells overexpressing wt or the Q64L mutant form of Rab22a, 
EEA1-positive early endosomes of normal size were practically absent and most of 
the EEA1 was collected to large vesicular structures. This phenomenon was similar to 
that observed with the Rab5a GTPase deficient mutant Q79L. Rab5a is another early 
endosomal Rab protein that regulates transport between the plasma membrane and 
early endosomes as well as regulating homotypic early endosomal fusion (Gorvel et 
al., 1991; Stenmark et al., 1994). When Rab5 Q79L and Rab22a wt were expressed in 
the same cells they co-localised to the same structures (data not shown). However, 
Rab5a wt is unable to form enlarged early endosomes as efficiently as wt Rab22, 
indicating that Rab22a may be a stronger stimulator of early endosomal fusion than 
Rab5a. The dominant inhibitory mutant of Rab22a, S19N, appeared mainly cytosolic, 
often with additional bright staining in the perinuclear region. The size and 
distribution of EEA1 positive early endosomes was normal in S19N overexpressing 
cells (I, Fig.1 M-O).   
 
1.2 Interaction of Rab22a with EEA1 
 
1.2.1 Yeast two-hybrid assay 
 
Rab5a shows the highest sequence similarity to Rab22 and both proteins share 
similarities in their cellular localisation and behaviour as well. Rab5 is known to 
interact directly with EEA1, which is one of the effector proteins of the GTPase. 
However, EEA1 does not interact with the other endosomal Rab proteins, Rab4 and 
Rab11. Rab5 interaction occurs at both ends of the long EEA1 molecule (Simonsen et 
al., 1998). We used the yeast two-hybrid assay to establish whether Rab22a associates 
with EEA1. To facilitate nuclear transport in yeast, we used Rab22a cDNA (wt and 
mutants) without the C-terminal double cysteine motif that mediates membrane 
association. Three EEA1 fragments were used, full length, the N-terminal part (amino 
acid residues 1-209) and the C-terminal part (amino acid recidues 1275-1411). The N- 
and C-terminal fragments were both known to contain the Zn2+-binding motif as well 
as the binding motif for Rab5. Rab22a cDNAs were used as bait and EEA1 cDNA 
constructs as prey. The active mutant of Rab22a, Q64L, was the only form showing 
binding affinity to full-length EEA1. The N-terminal part of EEA1 interacted with 
Q64L whereas the C-terminal part of EEA1 showed no binding at all. Interestingly, wt 
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Rab22a did not show affinity to any of the EEA1 forms. One possible explanation 
could be that yeast cells activate GTP hydrolysis by Rab22a more efficiently than 
mammalian cells. The dominant inhibitory mutant S19N did not show any binding to 
EEA1. These results indicate only an interaction between the GTP-bound form of 
Rab22a and EEA1. The binding site is only at the N-terminal region of EEA1, which 
is in contrast to the binding of Rab5, which occurs via motifs at both ends of the long 
protein (Fig.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. A model of the EEA1 monomer. EEA1 has two zinc binding motifs, one at each end of the 
protein (H2C2 and FYVE finger domain). N-terminal and C-terminal fragments that were used in this 
study are shown above. Both fragments include a binding site for Rab5. 
 
 
1.2.2 In vitro binding  
 
An in vitro pull-down assay was used to confirm the yeast two-hybrid data. 
Glutathione-S-transferase (GST)-tagged fusion proteins of Rab22a and Rab5a were 
expressed in E. coli and then coupled to glutathione sepharose beads. The beads were 
loaded with either GDP or the non-hydrolyzable GTP analogue, GTP?S. The pull-
down assay was carried out with the same N-terminal EEA1 fragment that was used 
in the two-hybrid assay and the results were analysed by Western blotting. Both of the 
Rab proteins showed a similar binding pattern; GTP?S loaded proteins bound strongly 
to the N-terminal form of EEA1, whereas the GDP loaded proteins gave only a weak 
signal (I, Fig.2). However, to obtain the same signal, 5-10 times less Rab22a was 
required than Rab5, indicating stronger binding by Rab22a. 
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Rab22a
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1.2.3 Phosphatidylinositol-3-phosphate kinase inhibition 
 
To gain further evidence of the interaction between Rab22a and EEA1 in vivo, we 
used the phosphatidylinositol-3-kinase (PI(3)K) inhibitor Wortmannin. EEA1 binds 
the PI(3)K product, phosphatidylinositol-3-phosphate (PI3P), via a C-terminal Zn2+-
binding domain called FYVE-finger. Kinase inhibition by Wortmannin causes 
detachment of EEA1 from early endosomal membranes. This effect is overcome by 
overexpressing Rab5 (Simonsen et al., 1998). Rab22a wt was expressed in BHK-21 
cells that were treated with Wortmannin. The cells were then fixed and stained with 
EEA1 antibody. Following Wortmannin treatment, the characteristic small spot-like 
EEA1 staining was extremely weak in the control cells due to detachment of EEA (I, 
Fig.3 B,D). However, in Rab22a overexpressing cells, staining of early endosomal 
membranes remained strong, thus indicating that Rab22a was able to maintain EEA1 
on the large early endosomal structures (I, Fig.3 A,C).  
The results from the yeast two-hybrid assay, the pull-down assay and the 
Wortmannin treatment showed that Rab22a binds most likely only to the N-terminal 
part of EEA1, like Rab5. No binding was observed at the C-terminal part of EEA1 
where another Rab5 binding site is located. This indicates that the function of Rab22a 
on early endosomal membranes is essentially distinct from that of Rab5a. Rab22a is 
incapable of forming symmetric bridges (via EEA1) between early endosomes the 
way Rab5a does. In vitro, Rab22a showed stronger affinity to EEA1 than Rab5a but it 
is not known whether Rab22a can compete for EEA1 binding with Rab5a, or whether 
the N-terminal binding site is the same for these two Rab proteins. It is likely that 
Rab22a participates in an early endosomal sorting process, together with other early 
endosomal Rab proteins. Rab effectors that bind the GTP bound form of Rab proteins 
are suggested to serve as a platform for multiple endosomal proteins and to connect 
different Rab domains on early endosomal membranes. Rab5 and Rab22a share the 
same effector protein, EEA1. Rab5 also shares the effector proteins Rabenosyn-5 and 
Rabip4 with Rab4 (de Renzis et al., 2002; Fouraux et al., 2003). Other effectors of 
Rab22a are not known but Rab22a may share more effectors with other Rab proteins. 
All these combinations reflect the complex sorting function of early endosomes. 
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1.3 Effects of Rab22a overexpression on endocytic functions 
 
1.3.1 Transferrin endocytosis 
 
Rab5a wt and its GTPase deficient mutant, Q67L, enhance transferrin (Tfn) 
endocytosis and at the same time the Q67L mutant inhibits Tfn recycling back to the 
plasma membrane (Bucci et al., 2000; Stenmark et al., 1994). We studied the effects 
of Rab22a on this Tfn pathway. HeLa cells were chosen for their abundant Tfn 
receptor expression. Rab22a or its mutant forms were expressed by using Vaccinia T7 
infection followed by Rab22 cDNA transfection. Alexa labelled Tfn was internalised 
into the cells and visualised by confocal microscopy. In HeLa cells, Rab22a only 
rarely causes abnormal vacuole-like endosomes. In this cell line, early endosomal 
staining remained more evenly distributed as fine vesicular structures. In the cells 
expressing wt Rab22a there was no change in the amount or distribution of 
internalised Tfn after 30 min as compared to control cells (I, Fig.4 C-E). The Alexa-
Tfn staining pattern was also similar in cells expressing a dominant inhibitory mutant, 
S19N (I, Fig.4 I-K). Overexpression of the GTPase deficient mutant Q64L did not 
affect the size of Tfn-positive endosomes, however, the distribution was changed. 
Instead of a relatively even cytoplasmic distribution, the Tfn-positive endosomes were 
clustered near the cell surface at the leading edges (I, Fig.4 F-H). However, the 
kinetics of Tfn endocytosis or recycling was not impaired. This was studied in COS-1 
cells transfected with Rab22a wt or mutant cDNAs and with biotinylated Tfn. As 
compared to untransfected or mock transfected cells, the cells expressing Rab22 wt, 
S19N or Q64L, showed no significant difference in the kinetics of either Tfn uptake 
or recycling (Fig.9). 
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Figure 9. The effect of Rab22a overexpression on the transferrin cycle. A. Transferrin uptake. COS-1 cells 
were transfected for 24 h with Rab22a wt or mutant cDNAs in pcDNA3.1, together with a human transferrin 
receptor (TfR) cDNA. Biotin-transferrin was bound on cell surfaces at 0oC, and the uptake was measured as 
described in Materials and Methods. The 0-time point background of cell surface-bound transferrin remaining on 
the mock-transfected cells after the holo-transferrin wash has been subtracted. The values are taken as an average 
of two independent experiments performed in triplicate. B. Transferrin recycling. COS-1 cells were transfected as 
above and incubated with biotin-transferrin for 2 h at 17oC to accumulate the tracer in endosomes. Recycling at 
37oC was assessed as depicted in Materials and Methods. The symbols are the same as in A. For each curve, the 
value at 0-time point, the starting point after transferrin loading, has been set at 1. Mean values +/- SEM from three 
independent experiments, performed in duplicate, are shown. 
 
  
1.3.2 Uptake of the fluid phase marker TRITC-dextran 
 
Early endosomes also take up fluid phase cargo molecules from the plasma 
membrane, however, this pathway is not receptor mediated like the Tfn pathway. To 
test fluid phase uptake in Rab22 overexpressing cells we used fluorescently labelled 
(TRITC) dextran as a fluid phase marker. The transfected BHK cells were allowed to 
endocytose dextran for 1 h, followed by a 3 h chase without dextran. After a 1 h 
internalisation period, dextran remained partly in EEA1 containing early endosomal 
structures in the mock transfected cells. During the 3 h chase dextran reached late 
endosomal structures that were positive for LAMP (I, Fig.7 A-E). A majority of the 
cells expressing wt Rab22a or the S19N mutant form transported dextran similarly to 
mock-transfected cells. Even though the EEA1-containing early endosomes were 
enlarged in wt Rab22 transfected cells, Dextran reached late endosomal structures 
during the incubation (I, Fig.7 F-J, P-T.) In these cells, dextran was not seen in EEA1 
positive early endosomal structures after 1 h internalisation, same was seen in control 
cells. Therefore, Dextran seemed to reach late endosomes directly without passing 
through enlarged Rab22 positive early endosomes. In the cells expressing the active 
mutant Q64L the situation was different. Dextran was found inside large vacuolar 
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structures that were positive for EEA1 and in some cases also for LAMP1. 
Accumulation of dextran was already observed after 1 h internalisation but not in 
every enlarged endosome (I, Fig.7 K-O). 
  
1.3.3 Degradation of epidermal growth factor 
 
The effects of Rab22a on endosomal membrane trafficking were further studied by 
monitoring the uptake and degradation of epidermal growth factor (EGF) in the Hep2 
cell line in which the EGF binding and uptake is highly efficient. The EGF receptor 
level must be down-regulated rapidly after receiving the ligand. Therefore EGF is 
internalised with its receptor and transported through endosomal structures called 
multi-vesicular bodies (MVBs) to lysosomes for degradation. MVBs are endosomal 
structures that are negative for M6PR and LAMP (Futter et al., 1996). Hep2 cells 
were transfected with Rab22a cDNAs by using the Vaccinia T7 system. Fluorescently 
(rhodamine) labelled EGF was internalised for 1 h, followed by a 3 h chase and 
fixation of the cells. In Hep2 cells, the Rab22 positive endosomal structures were 
similar to those in HeLa cells. Even in the cells expressing wt Rab22a or the Q64L 
mutant form, endosomes were small and rather similar to those in non-transfected 
cells. After 1 h internalisation, EGF was found in Rab22a wt positive endosomal 
structures (I, Fig.5 A-C) and remained there even after the 3 h chase (I, Fig.5 D-F). 
However, in non-transfected cells, EGF was degraded during 3 h chase time and no 
fluorescence was observed. The same effect, albeit less pronounced, was observed in 
cells expressing Rab22a Q64L (I, Fig.5 G-L). Surprisingly, Q64L did not colocalise 
with the marker after 1 h internalisation or after 3 h chase time even though both wt 
and Q64L mutant protein clearly inhibited the degradation of EGF. The degradation 
was quantified by calculating the proportion of transfected cells that displayed EGF 
positive endosomal elements after the 3 h chase (I, Fig.6). The highest frequency of 
such cells was observed in cultures expressing wt Rab22a (84%). In the cultures 
expressing Q64L, the frequency was somewhat lower (70%) and the lowest 
percentage (44%) was in S19N cultures. Also in cells expressing the S19N mutant, the 
frequency was elevated as compared to mock-transfected cells (17%), but the 
statistical variance of the quantitation was high in S19N expressing cells. The S19N 
mutant protein did not colocalise with EGF either at any of the time points (I, Fig.5 
M-R).    
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1.3.4 Analysis of the intracellular trafficking of AGA 
 
To elucidate the possible effects of Rab22a on protein trafficking from the 
biosynthetic pathway to endosomes, we followed the transport of human 
aspartylglucosaminidase (AGA). AGA is a lysosomal hydrolase that is transported 
through endosomes to lysosomes via the M6PR-mediated pathway (Enomaa et al., 
1995; Tikkanen et al., 1997). AGA and Rab22 wt or mutant forms were co-expressed 
in BHK cells by using a transient transfection. The proteins were expressed for 24 h, 
followed by 3 h incubation in the presence of cycloheximide (CH). CH prevents 
protein translation and therefore allows AGA to chase through the biosynthetic 
pathway to the lysosomes.  The cells were triple immunostained for AGA, EEA1 
(early endosomes) and LBPA (late endosomes, inner membrane), or in some 
experiments Rab22 was visualised instead of LBPA. In mock transfected cells AGA 
was chased to LBPA-containing structures which were negative for EEA1 (I, Fig.7 A-
E). In cells expressing wt Rab22a, the transport of AGA into late 
endosomes/lysosomes proceeded in a normal fashion despite the presence of large 
EEA1 positive early endosomes (I, Fig.8 F-J). In most of the cells (>85%) expressing 
Rab22a Q64L, the AGA accumulated in large endocytic compartments that were 
positive for both EEA1 and LBPA (I, Fig.8 K-O). However, similar to the fluid phase 
marker TRITC-Dextran, AGA did not accumulate in every large endosome. 
Expression of Rab22a S19N had no apparent effect on the trafficking of AGA (I, 
Fig.8 P-T).  
 Several experiments reported in this thesis on known early endosomal 
trafficking routes provided evidence for a role of Rab22a in early endosomal sorting. 
Rab22a did not affect transferrin endocytosis or recycling but the distribution of 
transferrin was changed in Q64L overexpressing cells. This is most likely due to 
influence of Rab22a on motor proteins involved in motility of early endosomes 
(Pfeffer, 1999). However, trafficking steps on the endocytic pathways were partly 
impaired; the active mutant Q64L caused accumulation of both dextran and EGF. In 
addition, overexpression of Rab22a wt inhibited the degradation of EGF and the 
protein was collected to the same structures with it. The EGF experiments indicate 
that Rab22a-positive endosomes/MVBs are unable to communicate with lysosomes. 
Also, dextran was unable to move to late endocytic compartments, and the lysosomal 
enzyme AGA accumulated inside Rab22a Q64L-positive vesicles containing partly 
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late endosomal/ lysosomal markers. One common feature was that only a few of the 
enlarged Rab22a Q64L-endosomes accumulated the studied marker proteins, most of 
the structures being devoid of the marker. This data indicates that upon 
overexpression of Rab22a Q64L the enlarged early endosomes appear first and then 
start to acquire late endosomal markers. It is possible that the Q64L mutant causes fast 
retrograde transport from late to early endosomes and therefore blocks some cargo to 
early endosomes or pushes it there from later compartments. 
                               
1.4 Effects of Rab22a overexpression on the Golgi apparatus 
 
Rab22 wt and Q64L overexpression caused a trafficking defect from the biosynthetic 
pathway to endosomes. This observation raised the question, is trafficking abnormal 
already in the Golgi complex? A simple Golgi immunofluorescence triple-staining 
experiment was done with two Golgi markers, mannosidase II (a Golgi resident 
enzyme, cis-/medial-Golgi marker) and GM-130 (a Golgi matrix protein, cis-Golgi 
marker, respectively). Simultaneously with the Golgi marker, antibodies against 
Rab22a and EEA1 were used. BHK-21 and HeLa cells were transfected with Rab22 
wt or mutant cDNA constructs for 24 h. Overexpression of Rab22 wt or Q64L mutant 
caused complete fragmentation of the Golgi in HeLa cells (I, Fig.9 A-J). Both of the 
Golgi markers were redistributed into small vesicular structures all over the cell 
periphery but did not mix with EEA1 containing early endosomal structures. The 
phenomenon was also seen in BHK cells but it was not prominent in this cell line. The 
Golgi had a normal compact structure in S19N overexpressing cells (I, Fig.9 K-O). 
The effects of Rab22a on the Golgi apparatus were unique among the early endosomal 
Rab proteins studied: Rab4, Rab5, Rab7 and Rab11 did not cause this effect.  
The finding that EEA1 binds syntaxin 6 with its C-terminal part (Simonsen et 
al., 1999) provides a possible mechanistic link between Rab22a function and early 
endosomal trafficking. Syntaxin 6 is a t-SNARE protein in the TGN. Interestingly, a 
yeast EEA1-like protein Vac1p regulates the TGN to endosome trafficking. Even 
though Rab22a Q64L causes the partial mixing of early and late endosomal marker 
proteins, the Golgi markers remain separately distributed. Studies of Rab1 suggest 
that one Rab protein can bind its effector proteins/vesicle tethering factors in both 
donor and acceptor membranes (Moyer et al., 2001). It is possible that Rab22a 
interacts with a yet unknown Golgi tethering factor and causes Golgi fragmentation 
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when it is present in excess amounts. Also, possible interactions with microtubular 
elements can cause fragmentation of the Golgi complex. Studies of the endocytic 
route indicate a function of Rab22a Q64L in retrograde transport (from late to early 
endosomes) but the Golgi fragmentation data suggest that Rab22a may function 
already in the TGN, maybe mediating trafficking between the TGN and early 
endosomes.   
 
 
2. Characterisation of a mammalian Sec1/Munc18 (SM) protein Munc18b 
 
2.1 Design of Munc18b mutants 
 
Three mammalian SM proteins control trafficking at the plasma membrane of 
different cell types. Munc18a (also know as Munc18-1/rbSec1/n-Sec1) is a neuronal 
protein, which binds neuronal syntaxin1A and B as well as syntaxins 2 and 3 (Hata 
and Südhof, 1995; Katagiri et al., 1995; Tellam et al., 1995). Munc18b (also known as 
Munc18-2) is mainly expressed in epithelial cells and interacts with plasma membrane 
syntaxins 2 and 3 (Hata and Südhof, 1995; Katagiri et al., 1995; Riento et al., 1998; 
Riento et al., 1996; Tellam et al., 1995). The ubiquitously expressed Munc18c (also 
know as PSP in platelets) binds to syntaxins 2 and 4, and has been shown to regulate 
glucose transporter trafficking in adipocytes and platelet granule exocytosis (Reed et 
al., 1999; Tamori et al., 1998; Tellam et al., 1997; Tellam et al., 1995; Thurmond et 
al., 1998). In order to gain further insight into the function of Munc18b and the roles 
of different plasma membrane syntaxins in epithelial cells, we generated a set of 
Munc18b point mutations. The mutants were designed according to three different 
criteria. The first set of mutations was generated based on mutations discovered in 
genetic studies on other known SM proteins. Identification of the correct amino acid 
to be mutated is, however, not certain in all cases, since the sequences of SM family 
members are markedly divergent in some regions. The second set was based on highly 
conserved sequence regions among different SM species, which were then mutated in 
Munc18b. The last group was based on a molecular model of the Munc18b-syntaxin 3 
complex. During the generation of the first two sets of mutants there was no 3D-
structural information available from SM proteins. When the last set of mutations was 
generated the neuronal Munc18a-syntaxin1A crystal structure was solved and based 
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on that, together with sequence alignments of different syntaxins and SM proteins, we 
created a homology model for Munc18b and syntaxin 3 (Fig.10; III, Fig .1 and Fig.2). 
 
Figure 10. Two ribbon representations of the structural model of the Munc18b-syntaxin 3 complex. 
The the side chains of residues subjected to mutagenesis in the present study are shown in red 
(positively charged), blue (negatively charged), violet (polar) and yellow (aromatic). In panel A, group 
I and group II mutations are shown. These mutations were generated according to other known 
mutations in SM proteins or from conserved sequence regions among different species. Panel B 
represents group III mutations, that were generated to alter the binding specificity of Munc18b to 
syntaxins. 
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Munc18b is the closest relative of Munc18a showing overall sequence identity of 
63%. The third set of mutants was designed to alter the binding specificity of 
Munc18b to syntaxin 2 and 3.  All Munc18b mutant forms are presented in Table V, 
where the three groups described above are identified with roman numerals I, II and 
III. Predictions in group III are based on the analysis of Munc18b-syntaxin3 binding 
interface in the homology model, and on comparison of differences in syntaxin1A, 2 
and 3 sequences.  
 
Table V. Munc18b mutations used in this study 
GROUP MUTATION CORRESPONDS TO 
I D34N/M38V Munc18a D34N/M38V, abolishes syntaxin 1A binding 1  
 P242S  Drosophila ROP P254S, increase of evoked neurotransmission 2  
 H293Y Drosophila ROP H302Y, reduction in evoked and spontaneous 
neurotransmission 2 
 R405P S.c. sec1-11 temperature sensitive (ts) mutation R432P 3 
 G416E S.c. sec1-1 ts mutation G443E, post-Golgi secretion arrest at the 
restrictive temp. 4 
 G416W a bulky hydrophobic residue at the position G416 
 E467K S.c. SLY1-20 E532K, a dominant single copy suppressor of 
deletion of YPT1  5 
II P187A  highly conserved proline which can affect the neighboring 
secondary structures 
 K314L/R315L conserved residues  
 G541E highly conserved glycine  
III W28S predicted to be a non-binder for syntaxin 1A, 2 and 3 
 S42K predicted to bind only syntaxin 2 and 3 
 S48D predicted to bind only syntaxin 2 
 E59K predicted to be a non-binder for syntaxin 1A, 2 and 3 
1 Naren et al. 1997; 2 Wu et al. 1998; 3 Aalto et al. 1991; 4 Novick et al. 1980; 5 Dascher et al. 1991 
 
 
2.2 Basic characterisation of the mutants 
 
2.2.1 Stability test 
 
The stability of all the Munc18b variants constructed was tested. The mutant proteins 
were all N-terminally myc-tagged and contained one (or two in some constructs) 
amino acid point mutation, which may (in principle) affect the stability of the protein. 
The proteins were overexpressed in Caco-2 cell by using the recombinant SFV 
expression system. The cells were infected for 4 h at which time the expression was 
approximately 5-fold as compared to the endogenous protein. The cells were 
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metabolically labelled with [35S]  Met/Cys for 0.5 h followed by 2 h chase. The cells 
were lysed right after pulse or after chase, immunoprecipitated with myc-antibody, 
and further analysed by SDS-page and fluorography. The mutants fell into three 
stability categories. K314L/R315L, E467K, and all mutants in Group III, were as 
stable as wt Munc18b. Almost all proteins in Group I (G416E, G416W, R405P, 
P242S, H293Y) showed a mild decrease after a 2h chase (50-80% of the amount of 
labelled protein remaining after chase). The rest of the mutants (D34N/M38V, P187A, 
G541E) were remarkably unstable (20-25% remaining after chase). These results 
confirm the important structural role of the conserved amino acids Pro187 and Gly541 in 
SM proteins. However, in the overexpression situation, the amount of even the 
unstable protein variants at the expression rate reached with the SFV vector were high 
enough for biochemical studies to be carried out (II, Fig.3, Table I; III, Fig.4). Several 
of the mutated residues in groups I and II were found to be located in the model far 
from the syntaxin binding interface (Fig. 10A), suggesting that the effects of these 
mutations are due to distortion of the SM protein conformation or a defective 
interaction with potential non-syntaxin binding partners (mutations at the surface of 
the predicted Munc18b structure).  
 
2.2.2 In vitro binding assays 
 
All mutant proteins were tested for their syntaxin 3 binding ability in vitro and in vivo. 
In vitro binding was performed by using a GST-tagged syntaxin bound on a 96-well 
plate. In vitro translated and [35S] Met/Cys labelled Munc18b variants were incubated 
on the plate at 37°C, and the bound Munc18b was measured by scintillation counting. 
Also, unlabelled Munc18b was used to compete specific binding. Optimisation with 
different amounts of labelled Munc18b and the competition showed that the binding 
assay was highly specific and gave a linear response in the entire radioactivity range 
used (II, Fig.2). In Group I, the counterpart of yeast sec1-temperature sensitive 
mutation G416E bound syntaxin 3 at roughly 50% efficiency compared with the wt 
protein. The other mutant protein related to yeast sec1-temperature sensitive mutation, 
R405P, showed no detectable binding to syntaxin 3. The binding did not change when 
the incubation was done at 24°C. When amino acid Gly416 was replaced with a bulky 
hydrophobic tryptophan (G416W) the binding was more reduced (~90%) than for 
G416E, indicating more extensive structural distortion than with the smaller charged 
 51
residue. Both ROP related mutations, H293Y and P242S, showed only negligible 
association with syntaxin 3 similar to the neuronal Munc18a based mutation 
D34N/M38V, which abolishes syntaxin 1A binding of Munc18a as well. 
Interestingly, the counterpart of yeast sly1-20 mutation, E467K, displayed enhanced 
binding to syntaxin 3. The novel mutations in group II, K314L/R315L, P187A and 
G514E, showed no detectable or extremely weak binding to syntaxin 3 (II, Fig.2, 
Table I). The fact that the counterparts of the loss-of-function mutations in other SM 
proteins all show defects in syntaxin binding supports the idea that syntaxin 
interaction is a major functional feature of SM proteins. 
The binding of Group III variants to other plasma membrane syntaxins (1A, 2, 
3 and 4) was tested with a similar plate assay. In this assay, wt Munc18b shows the 
highest binding to syntaxin 2 (100%) and the apparent binding efficiency for syntaxin 
3 is about 50% of syntaxin 2. The wt protein binds syntaxin 1A with roughly 25% of 
the syntaxin 2 binding efficiency. There was no detectable binding to syntaxin 4.  
W28S, S42K and E59K did not show any binding to the syntaxins tested. S48D 
showed highly reduced binding to syntaxin 3 whereas its binding efficiency for 
syntaxin 1A and 2 remained close to wt levels. This mutant and the non-binder 
mutants, W28S and E59K, behaved according to the created model and could be used 
in assays in which selective syntaxin binding efficiency or totally abolished syntaxin 
binding is needed. K314L/R315L was tested in this assay as well. Compared to the wt 
protein, K314L/R315L showed decreased binding to syntaxin 1A and 2 and the 
binding to syntaxin 3 was significantly reduced but detectable as compared to the wt 
protein (III, Fig.3). 
 
2.2.3 In vivo binding assays 
 
In vivo binding assays were performed using SFV-mediated overexpression and myc-
immunoprecipitation. The precipitated proteins were analysed by SDS-PAGE and by 
Western blotting with anti-syntaxin 3 antibody (and with anti-syntaxin 2 antibody for 
Group III mutants). For quantification, the results from Group I and II mutants were 
analysed by using [35S]-protein A and the phosphorimager technique.  
In vivo results coincided well with the in vitro results. The in vitro analysis 
was, however, more sensitive and some mutants that showed a weak but detectable 
signal in the in vitro binding assay, showed no binding in vivo (D34N/M38V, 
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K314L/R315L, P187A, P242S and H293Y). This could also indicate the presence of 
some other factors that can regulate the binding in vivo or in some cases the result 
could be due to reduced stability of the mutant (D34N/M38V, P187A, G541E) in the 
living cells. Also, an increase of E467K syntaxin 3 binding was seen in vivo (II, Fig.4, 
Table I; III, Fig.5), as suggested by the in vitro results. 
 
2.2.4 SNAP-23 displacement 
 
All Group I and II mutant proteins were tested for their ability to displace SNAP-23 
from syntaxin 3-based SNARE complexes. Overexpressed wt Munc18b disrupts 
apical SNARE complexes containing syntaxin 3, SNAP-23 and cellubrevin (Riento et 
al., 1998). The displacement studies were carried out in Caco-2 cells using a similar 
SFV infection as above and immunoprecipitation with syntaxin 3 antibody. The 
precipitates were analysed by Western blotting with anti-SNAP-23 antibody and 
quantified with 35S-protein A and the phosphorimager technique. Overexpression of 
wt Munc18b decreased the amount of SNAP-23 bound to syntaxin 3 by 50% 
compared with the control-infected cells. The ability of the mutant proteins to displace 
SNAP-23 from the complex correlated reasonably well with their ability to bind 
syntaxin 3. The strongest syntaxin 3 binder in vitro and vivo, E467K, showed similar 
displacement ability as the wt Munc18b. The only exception was H293Y (counterpart 
of Drosophila ROP H302Y mutation), which did not bind syntaxin 3 in vivo but was 
still able to reduce the amount of SNAP-23 in the immunoprecipitates. However, this 
mutant interacted with syntaxin 3 in vitro, so it is possible that some interaction 
occurs also in the overexpression situation in vivo.  
 
2.2.5 Membrane association 
 
The Group I and II mutants were tested for their ability to associate with cellular 
membranes. These mutants were non-binders or weak binders for syntaxin 3. Caco-2 
cells were infected with SFVs expressing wt Munc18b or the mutant forms for 4h. 
The cells were collected and the membranes were separated by sucrose gradient 
centrifugation from the post-nuclear supernatant. Fractions were precipitated and 
analysed by Western blotting. Under these conditions, syntaxin 3 was only in the 
membrane fraction and a cytosolic control protein gelsolin in the soluble bottom 
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fraction. It is known that overexpressed wt Munc18b localises to the apical plasma 
membrane of Caco-2 cells with simultaneously expressed syntaxin 3 (Riento, 1999). 
When overexpressed alone, Munc18b seems to be mainly cytosolic in 
immunofluorescense microscopy studies but its membrane association has not been 
addressed. Now in sucrose gradient centrifugation, wt Munc18b showed clear 
membrane association although a small part of it remained cytosolic. In control 
infected cells, the distribution of endogenous Munc18b was similar. Interestingly, 
mutant proteins D34N/M38V, K314L/R315L and P242S also showed membrane 
association in the absence of syntaxin 3 binding. A major part of these proteins was 
found in the membrane fraction (II, Fig.6). These results indicate that Munc18b can 
be membrane associated independently of syntaxin 3. It is possible that the interaction 
occours via other plasma membrane syntaxins even though the other Munc18b 
binding plasma membrane syntaxins, syntaxin 1A and syntaxin 2, are not abundant in 
Caco-2 cells. 
 
2.3 Functional studies 
 
2.3.1 Assay of HA trafficking by surface immunoprecipitation 
 
Munc18b is mainly expressed in epithelial cells but its function in polarised 
trafficking is unknown. To elucidate this question we did two types of trafficking 
assays with the marker protein influenza virus hemagglutinin HA. HA is a well-
characterised apically transported protein (Matlin and Simons, 1984; Rodriguez-
Boulan et al., 1984). We generated double-SFVs, where HA and Munc18b were both 
expressed separately under two independent promoters. This approach guaranteed that 
both proteins were expressed in the same cells. SFV infection causes host protein 
synthesis shut-off. Therefore it was not possible to monitor transport of endogenous 
proteins. Filter-grown polarised Caco-2 cells were infected with double-SFVs 
encoding HA and wt Munc18b or variants (D34N/M38V, K314L/R315L, P242S). 
The cells were pulse-labelled with [35S] Met/Cys followed by a 2h chase. Antibody 
against HA was added to the cells and allowed to bind to surface exposed HA protein 
on either apical or basolateral membranes. The cells were lysed and 
immunocomplexes were precipitated with protein A-sepharose. The total amount of 
HA was also analysed by adding the antibody to the lysed cells. Precipitates were 
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analysed by Western blotting. HA appears in two different forms, an 80 kDa fully 
glycosylated form and a smaller 70 kDa high mannose form likely to represent protein 
in the ER or Golgi. This latter form was predominant in the Caco-2 cells (II, Fig.7A). 
In control-infected cells HA was transported to both membrane domains. Even though 
transport of HA to the apical domain of Caco-2 cells is well characterised (Jacob et 
al., 1999; Zurzolo et al., 1992), it is possible that some influenza strains behave 
differently. Alternatively, under the growth conditions used, the specific Caco-2 cell 
clone may not transport HA faithfully to only the apical membrane. This unpolarised 
trafficking made it possible for us to monitor trafficking to both membrane domains. 
In wt Munc18b infected cells the amount of HA on apical membranes was 30% lower 
than in control cells. The HA amount in basolateral membranes remained the same 
indicating that wt Munc18b inhibits selectively apical transport, not basolateral 
transport or trancytosis, in which the cargo molecules are transported via the 
basolateral membrane to the apical surface. All mutant forms of Munc18b selected for 
this study were unable to bind syntaxin 3 or were weak binders. Interestingly, all three 
behaved differently. D34N/M38V showed a similar 30% inhibition in apical transport 
as the wt protein, whereas K314L/R315L appeared to enhance HA apical delivery by 
approximately 50%. However, the results from K314L/R315L varied within a large 
range. P242S did not show any effect on HA transport. It is likely that the inhibition 
caused by the wt protein is due to syntaxin 3 binding of the overexpressed protein. Wt 
Munc18b most likely sequesters free monomeric syntaxin 3 and therefore prevents 
SNARE complex formation and exocytosis. However, D34N/M38V caused inhibition 
without capacity for syntaxin 3 binding and K314L/R315L enhanced apical transport 
of HA (Fig.11). These effects could be due to yet unknown factors which the mutant 
forms can bind and sequester or bring to the SNARE complex assembly site and 
thereby cause changes in regulation of the SNARE machinery. 
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Figure 11. Quantitation of HA transported to the distinct plasma membrane domains in Munc18b 
overexpressing Caco-2 cells. Polarised Caco-2 cells were infected with double-SVF viruses expressing 
both HA and Munc18b, or one of its variants. The cells were labeled for 2h with [35S] Met/Cys 
followed by a 2h chase. HA was surface-immunoprecipitated from apical and basolateral domains, 
respectively.  The amount of HA is divided by the total immunoprecipitated HA. The values obtained 
(±S.E., n=4) are presended relative to that of apically delivered HA in the control-infected (c) cells, 
which was set at 1. 
 
2.3.2 HA trafficking assay by confocal immunofluorescence microscopy 
 
Effects of Group III mutants, S48D and E59K, on HA trafficking were monitored by 
another method using a confocal microscope. Munc18b S48D binds only syntaxin 2 
with high affinity whereas E59K is a non-binder for any syntaxin. Different epithelial 
cells express the different syntaxins in different amounts. Caco-2 cells express mainly 
syntaxin 3 whereas MDCK II cells express syntaxin 2 more abundantly. The porcine 
kidney epithelial cell line LLC-PK1 produces both of the syntaxins in significant 
amounts (III, Fig.7). Endogenous syntaxin 3 is localised on apical membranes in 
Caco-2 cells (Delgrossi et al., 1997) where syntaxin 2A is also located (Quinones et 
al., 1999). In stably transfected MDCK II cells, syntaxin 3 was found in the apical 
domain whereas syntaxin 4 was in the basolateral part, showing no overlap with 
syntaxin 3 staining. Syntaxin 2 was found in both membrane domains, (Low et al., 
1996) which may represent different syntaxin 2 isoforms. Overexpressed syntaxin 2A 
localises to the apical plasma membrane in MDCK II (Quinones et al., 1999).  
We selected Caco-2 and MDCK II cells and monitored the influence of 
Munc18b S48D mutant form on apical transport of HA. Filter-grown polarised cells 
were infected with double SFVs expressing both, HA and Munc18b variant, followed 
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by a period with cycloheximide. The cells were fixed and stained with anti-HA 
antibody. The distribution of HA was monitored as the mean fluorescence intensity 
along the apical-basal axis with a confocal microscope. Four focal planes were 
selected in which the first was the apical plasma membrane and the last was the 
bottom of the cell (Fig.12).  
The wt Munc18b inhibited apical transport of HA in both cell lines compared 
to control infected cells. The inhibition was 33% in Caco-2 cells and 56% in MDCK 
II cells. Munc18b S48D caused 42% inhibition of apical transport in MDCK II cells 
but did not interfere with transport in Caco-2 cells. This is most likely due to selective 
binding of the S48D mutant to syntaxin 2, the major apical syntaxin in MDCK cells. 
The result suggests that in MDCK II cells, in which the function of syntaxin 3 in 
exocytic transport to the apical surface is well established (Lafont et al., 1999; Low et 
al., 1996), syntaxin 2 also plays an important role in this process. This indicates that 
different cell lines can use different plasma membrane syntaxins for the same task. 
The results obtained with the E59K mutant were unexpected. This mutant was 
originally assumed to have no effect on apical transport of HA since it lacks the 
syntaxin binding capacity but it caused clear inhibition of the apical distribution of 
HA in both of the cell lines used. Another mutant, K314L/R315L, with diminished 
syntaxin 2 binding affinity and weak syntaxin 3 affinity, did not significantly interfere 
with HA transport (Fig.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Four focal planes recorded from the HA trafficking assay by confocal 
immunofluorescence microscopy. The first plane, the apical plasma membrane, was selected above the 
tight junctions. The other planes were recorded at equal intervals, the fourth plane representing the 
basal surface. The mean fluorescence intensity was measured in each focal plane. 
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Figure 13.  The effect of Munc18b variants on apical transport of HA. Polarized Caco-2 (A) or 
MDCK II (B) cells, grown on filters, were infected with recombinant SFVs expressing either a non-
relevant control protein (ctrl), the wild-type Munc18b (wt) or mutant forms of Munc18b 
(K314L/R315L, S48D or E59K), together with influenza virus HA, as detailed in Methods. The cells 
were fixed and processed for immunofluorescence microscopy using HA antibodies. The distribution 
of HA along the apical-basal axis was quantified using a confocal microscope; a percentage distribution 
of mean fluorescence intensity at four focal planes is presented. 1, apical surface; 2, a plane at 1/3 the 
of cell thickness down; 3, a plane at 2/3 of the cell thickness down; 4, basal surface. The results 
represent the mean ? SEM from 20 cells analysed from each infection.  
 
Some of the results obtained from Munc18b variants are summarised in Table VI.  
 
Table VI. Summary of the results from Munc18b mutant forms 
 
 
ND, Not determined; #, HA trafficking by surface immunoprecipitation; * HA trafficking assay by 
confocal immunofluorescence microscopy 
 
 
HA TRANSPORT 
(% apical as 
compared to ctrl)
 
MUTATION 
(GROUP) 
 
 
STABILITY 
In vitro 
Syn2 
BINDING
In vitro 
Syn3 
BINDING
 
SNAP-23 
DISPLACEMENT 
Caco-2 MDCK 
wt +++ +++ +++ +++ -30 # -50 * 
D34N/M38V(I) +/- ND +/- ND -30 # ND 
P242S (I) ++ ND +/- ++ +/-0 # ND 
H293Y (I) ++ ND +/- ++ ND ND 
R405P (I) ++ ND ND ND ND ND 
G416E (I) ++ ND ++ ++ ND ND 
G416W (I) ++ ND +/- + ND ND 
E467K (I) +++ ND +++ +++ ND ND 
P187A (II) + ND +/- ND ND ND 
K314L/R315L(II) +++ ND +/- + +50 # -10 * 
G541E (II) + ND + ND ND ND 
W28S (III) +++ - - ND ND ND 
S42K (III) +++ - - ND ND ND 
S48D (III) +++ +++ +/- ND +/-0* -40 * 
E59K (III) +++ - - ND -25 * -40 * 
H
A 
% 
0
10
20
30
40
50
60
cont wt KR S48 E59
0
10
20
30
40
50
60
cont wt KR S48 E59
1
2
3
4
Caco-2 MDCK II 
 58
2.3.3 Amylase secretion from pancreatic acinar cells  
 
The pancreatic acinar cell has been a classic model to study regulated exocytosis 
occurring at the apical plasma membrane. The cytosol of the acinar cell is crowded 
with zymogen granules. Zymogens are synthesised as inactive proenzymes and are 
transported to the condensing vacuoles. These vacuoles undergo a series of maturation 
steps before ending up as large and dense mature zymogen granules, which are 
packed with high amount of proenzyme. When acinar cells are stimulated with 
cholecystokinin (CCK), the enzymes are released from the apical membrane to the 
pancreatic duct. This transport event is disturbed in acute pancreatitis. In this 
condition, the enzymes are secreted to the basal membrane where they cause severe 
tissue damage (Gaisano, 2000). We used pancreatic acinar cells type to study the 
effects of Munc18b on regulated exocytosis and measured the secretion of one 
enzyme, amylase, upon CCK analogue CCK-OPE stimulus. In acinar cells, the 
distribution of syntaxins is different compared to the previously used polarised cell 
lines; syntaxin 2 is located at the apical plasma membrane whereas syntaxin 4 is on 
the basal membrane and syntaxin 3 is on the zymogen granules (Gaisano, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. The effect of Munc18b variants on amylase secretion in pancreatic acinar cells. Rat acinar 
cells were isolated and infected with Adenoviruses expressing GFP (control), wt Munc18b, S48D or 
E59K. The cells were stimulated for secretion and the amount of secreted amylase was measured from 
the medium as detailed in the Methods section. The results represent the mean of five independent 
experiments ± s.e.m. For each Munc18b variant the difference from the GFP control is statistically 
significant (t-test; p< 0.0001).  
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Wt Munc18b expressed from an adenoviral vector caused ~30% inhibition of 
amylase secretion compared to control infected cells. Munc18b S48D, the mutant 
unable to bind syntaxin 3, inhibited amylase secretion at least as efficiently as the wt 
protein. Interestingly, Munc18b E59K, which is unable to bind any of the syntaxins 
studied, caused the most extensive, ~50%, inhibition (Fig.14). These results, together 
with those obtained in Caco-2 and MDCK II cells, indicate that the syntaxin 
interaction is not the only functionally relevant feature of Munc18b. It is evident that 
those mutant forms of Munc18b that are unable to bind syntaxin, are still capable of 
causing transport inhibition when overexpressed.  
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V SUMMARY AND CONCLUSIONS 
 
Cells contain a variety of transport vesicles that carry cargo molecules to different 
destinations. This process is necessary for cell organelles to maintain their unique 
features. Although many specific transport routes exist, the molecular mechanisms 
involved appear to be rather similar and conserved through evolution. SNARE 
proteins on the vesicle membrane and the target membrane play a key role in vesicle 
fusion. There are several regulators of SNARE complexes that adjust the specificity as 
well as the correct timing of the fusion event. The two main families of SNARE 
regulators are the Rab protein family and the Sec1/Munc18b (SM) protein family. In 
the present study, we have characterised the properties of a small GTPase Rab22a and 
an SM family member, Munc18b. 
 Rab22a is a novel, early endosomal Rab protein. Early endosomes are shown 
to be important sorting centres within multiple endocytic pathways. Several Rab 
proteins are localised to these organelles where they are suggested to form specific 
sorting domains. Effector proteins mediate the function of Rabs through binding to the 
GTP bound form of the GTPase. Each early endosomal Rab protein has its unique 
effector proteins but they also share some binding partners (Deneka and van der 
Sluijs, 2002). We found that Rab22a interacts directly with the N-terminal part of the 
early endosomal tethering factor EEA1 thus creating a functional link with the major 
early endosome transport regulator Rab5. Rab5 mediates the homotypic fusion of 
early endosomes and binds to both ends of the long EEA1 molecule. Since Rab22a 
binds only the N-terminal end of EEA1, the function must differ from the function of 
Rab5. Overexpressed Rab22a causes several trafficking defects in the endocytic 
pathway. The overexpressed GTPase deficient mutant of Rab22a leads to mixing of 
early and late endosomal markers. This could be due to enhancement of a retrograde 
pathway from early to late endosomes. In addition, both forms of Rab22a, wt and the 
GTPase deficient mutant, cause complete disruption of the Golgi complex when 
overexpressed. It is therefore possible that Rab22a interacts with another tethering 
factor in the Golgi complex. Interestingly, EEA1 binds with its C-terminal end to 
syntaxin 6, a t-SNARE in the TGN. These results indicate that Rab22a may have a 
function in communication between early endosomes and the TGN. Further studies 
are needed to prove this hypothesis. It would be interesting to study the role of 
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Rab22a in the intoxication by Shiga toxin, which is believed to enter the TGN via 
early endosomes (Johannes and Goud, 2000; Sandvig and van Deurs, 2002). 
Munc18b is mainly expressed in epithelial cells and interacts with plasma 
membrane syntaxins 2 and 3 (Hata and Südhof, 1995; Katagiri et al., 1995; Tellam et 
al., 1995). We showed that Munc18b has a role in apical exocytosis in several 
polarised cell types. The molecular model of the Munc18b/syntaxin 3 complex was 
used to design mutants with altered syntaxin binding properties. The mutant S48D 
that binds only to syntaxin 2 provides evidence that different epithelial cells can use 
different syntaxins for the same task. The mutations in conserved amino acid residues 
(P187A and G541E) cause rapid degradation of Munc18b, indicating the important 
structural function of these amino acids in the correct folding of the protein. The 
mutants designed according to loss-of–function mutations in other SM proteins all 
have defects in syntaxin binding, supporting the idea that syntaxin interaction is a 
major functional feature of SM proteins. However, behaviour of the non-binder/weak 
binder mutants in the functional assay suggest that also other interaction partners must 
be highly important. Also, the fact that some syntaxin non-binder mutants associate 
with membranes supports this idea. In the present study it has been a frequent 
observation (with several cell lines and several different assays) that Munc18b 
mutants that show no or drastically reduced affinity for syntaxin behave in different 
ways in apical transport assays. Some of the mutants seem functionally inert while 
others have effects comparable to those of the wt protein.  
Data obtained with non-binder or weak binder mutants allow us to suggest the 
following model (Fig.15). In this model Munc18b with a low affinity for syntaxin 
(such as K314L/R315L) is still capable of performing its essential function by 
associating with the syntaxin at a high turnover rate and recruiting a yet unknown 
essential factor to the SNARE complex assembly site. The reduced affinity would 
compensate for the increased protein concentration due to over-expression, resulting 
in no inhibitory effect such as that caused by excess wt protein. However, an over-
expressed mutant with totally abolished syntaxin binding (like E59K), assuming that 
it is still able to bind the unknown cytosolic or membrane-associated factor, would 
sequester this factor and make it unavailable for the normal endogenous SM protein, 
thus leading to inhibition of transport. It is possible that SM proteins bridge the 
SNARE complex and the membrane tethering apparatus controlled by the Rab 
GTPases. In fact, there is evidence that several SM proteins interact with effectors that 
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Rab GTPases recruit to membranes. For example Rab5 effector Rabenosyn5 binds the 
SM family member hVPS45 and the S. cerevisiae tethering factor Vac1p has binding 
partners in both SNARE regulator families (Nielsen et al., 2000; Peterson et al., 1999; 
Tall et al., 1999). Creating temporal and spatial control between the tethering and 
docking/fusion steps is an absolutely essential but yet poorly understood process.  
 
 
 
 
Figure 15. Model for a common function of SM proteins. A. A transport vesicle is tethered at the 
target membrane via the action of a Rab protein in its GTP-bound form (GTP) and by a tethering 
complex (T) recruited to membranes by the small GTPase. The SM protein binds to factor X (or 
possibly several factors) and then to syntaxin (alternative a), or binds to syntaxin first and then recruits 
factor X (alternative b). SNARE proteins are marked with S. B. Factor X links the SM protein and the 
complexed syntaxin to the Rab-based tethering apparatus. C. The SM protein facilitates the assembly 
of a trans-SNARE complex in a spatially and temporally controlled manner. The tethering complex 
dissociates and the Rab in GDP-bound form (GDP), the SM protein, and factor X are released. In some 
cases, the SM protein may remain bound to the SNARE complex and regulate events during the 
following fusion process. 
 
To fully understand the role of SM proteins in vesicle transport we now need to 
investigate in great detail the function and the non-syntaxin interaction partners of 
different SM proteins with distinct modes of syntaxin binding. Furthermore, it is 
obvious that phosphorylation/dephosphorylation cycles of SM proteins and their 
binding partners play major roles in the regulation of vesicle docking and fusion 
(Craig et al., 2003; de Vries et al., 2000; Fujita et al., 1996; Sassa et al., 1996). 
Grasping the common functional principle of the SM proteins is a major task for the 
future and will undoubtedly represent a major leap in our comprehension of how cells 
control the essential but highly complex process of vesicle transport.  
 
 63
VI ACKNOWLEDGEMENTS 
 
This work was carried out at the National Public Health Institute at the Department of 
Biochemistry and Molecular Medicine during the years 1999-2004. I wish to express 
my gratitude to the following people: 
 
Former and present directors of the Institute, Professor Jussi Huttunen and 
Professor Pekka Puska, respectively, for providing the excellent research 
facilities 
 
Former and present heads of the department, Professor Christian Ehnholm and 
Professor Leena Palotie, respectively, for allowing me the opportunity to carry 
out my research in such a well-equipped and dynamic laboratory 
 
Professor Carl G. Gahmberg, from the Division of Biochemistry, University of 
Helsinki, for his assistance and flexibility in arranging the coursework 
component of my studies 
 
My supervisor Docent Vesa Olkkonen for his enthusiasm in my project, active 
collaboration and overall guidance throughout my studies  
 
My collaborators Dr. Sirkka Keränen, Dr. Kirsi Riento, Dr. Gerd Wohlfahrt 
and the group of Professor Harald Stenmark (Oslo, Norway), as well as the 
group of Dr. Herbert Gaisano (Toronto, Canada) for welcoming me into their 
laboratories and for providing me an inspiring environment that was enjoyable 
to work in 
 
Professor Elina Ikonen and Docent Matti Jauhiainen for their sound advice and 
enthusiastic discussions 
 
Docent Markku Saloheimo (VTT, Espoo) and Dr. Ulrich Blank (CNRS, Paris, 
France) for reviewing this thesis and providing useful comments 
 
Sarah Siggins for revising the language of the thesis 
 
Seija Puomilahti and Pirjo Ranta for their technical assistance during the 
project 
 
Everyone in the lab for the enjoyable atmosphere and scientific collaboration 
 
Family and friends for their unfailing help and support 
 
Helsinki Graduate School in Biotechnology and Molecular Biology for 
offering travel grants as well as many interesting courses and events 
 
The Finnish Cultural foundation, Instrumentariumin Tiedesäätiö, Farmoksen 
Tutkimus- ja Tiedesäätiö for financial support 
 
 64
VII REFERENCES 
 
Aalto, M. K., Jäntti, J., Ostling, J., Keränen, S., and Ronne, H. (1997). Mso1p: a yeast protein that 
functions in secretion and interacts physically and genetically with Sec1p. Proc Natl Acad Sci U 
S A 94, 7331-7336. 
Aalto, M.K., Keränen, S. and Ronne, H. (1992). A family of proteins involved in intracellular transport. 
Cell 68, 181-182 
Aalto, M. K., Ronne, H., and Keränen, S. (1993). Yeast syntaxins Sso1p and Sso2p belong to a family 
of related membrane proteins that function in vesicular transport. Embo J 12, 4095-4104. 
Aalto, M. K., Ruohonen, L., Hosono, K., and Keränen, S. (1991). Cloning and sequencing of the yeast 
Saccharomyces cerevisiae SEC1 gene localized on chromosome IV. Yeast 7, 643-650. 
Aniento, F., Emans, N., Griffiths, G., and Grüenberg, J. (1993). Cytoplasmic dynein-dependent 
vesicular transport from early to late endosomes. J Cell Biol 123, 1373-1387. 
Antonin, W., Fasshauer, D., Becker, S., Jahn, R., and Schneider, T. R. (2002). Crystal structure of the 
endosomal SNARE complex reveals common structural principles of all SNAREs. Nat Struct 
Biol 9, 107-111. 
Antonin, W., Holroyd, C., Fasshauer, D., Pabst, S., Von Mollard, G. F., and Jahn, R. (2000). A SNARE 
complex mediating fusion of late endosomes defines conserved properties of SNARE structure 
and function. Embo J 19, 6453-6464. 
Antonny, B., Madden, D., Hamamoto, S., Orci, L., and Schekman, R. (2001). Dynamics of the COPII 
coat with GTP and stable analogues. Nat Cell Biol 3, 531-537. 
Barbero, P., Bittova, L., and Pfeffer, S. R. (2002). Visualization of Rab9-mediated vesicle transport 
from endosomes to the trans-Golgi in living cells. J Cell Biol 156, 511-518. 
Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N., Rexach, M. F., 
Ravazzola, M., Amherdt, M., and Schekman, R. (1994). COPII: a membrane coat formed by Sec 
proteins that drive vesicle budding from the endoplasmic reticulum. Cell 77, 895-907. 
Block, M. R., Glick, B. S., Wilcox, C. A., Wieland, F. T., and Rothman, J. E. (1988). Purification of an 
N-ethylmaleimide-sensitive protein catalyzing vesicular transport. Proc Natl Acad Sci U S A 85, 
7852-7856. 
Bos, C. R., Shank, S. L., and Snider, M. D. (1995). Role of clathrin-coated vesicles in glycoprotein 
transport from the cell surface to the Golgi complex. J Biol Chem 270, 665-671. 
Bracher, A., Perrakis, A., Dresbach, T., Betz, H., and Weissenhorn, W. (2000). The X-ray crystal 
structure of neuronal Sec1 from squid sheds new light on the role of this protein in exocytosis. 
Structure Fold Des 8, 685-694. 
Bracher, A., and Weissenhorn, W. (2002). Structural basis for the Golgi membrane recruitment of 
Sly1p by Sed5p. Embo J 21, 6114-6124. 
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94. 
Brennwald, P., Kearns, B., Champion, K., Keranen, S., Bankaitis, V. and Novick, P. (1994). Sec9 is a 
SNAP-25-like component of a yeast SNARE complex that may be the effector of Sec4 function 
in exocytosis.Cell.;79(2):245-58 
Brummer, M. H., Kivinen, K. J., Jäntti, J., Toikkanen, J., Söderlund, H., and Keränen, S. (2001). 
Characterization of the sec1-1 and sec1-11 mutations. Yeast 18, 1525-1536. 
Bucci, C., Thomsen, P., Nicoziani, P., McCarthy, J., and van Deurs, B. (2000). Rab7: a key to 
lysosome biogenesis. Mol Biol Cell 11, 467-480. 
Burgoyne, R. D., and Morgan, A. (2003). Secretory granule exocytosis. Physiol Rev 83, 581-632. 
Calakos, N., and Scheller, R. H. (1994). Vesicle-associated membrane protein and synaptophysin are 
associated on the synaptic vesicle. J Biol Chem 269, 24534-24537. 
Carr, C. M., Grote, E., Munson, M., Hughson, F. M., and Novick, P. J. (1999). Sec1p binds to SNARE 
complexes and concentrates at sites of secretion. J Cell Biol 146, 333-344. 
Carroll, K. S., Hanna, J., Simon, I., Krise, J., Barbero, P., and Pfeffer, S. R. (2001). Role of Rab9 
GTPase in facilitating receptor recruitment by TIP47. Science 292, 1373-1376. 
Chant, J. (1994). Cell polarity in yeast. Trends Genet 10, 328-333. 
Christoforidis, S., McBride, H. M., Burgoyne, R. D., and Zerial, M. (1999a). The Rab5 effector EEA1 
is a core component of endosome docking. Nature 397, 621-625. 
Christoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S. C., Waterfield, M. D., 
Backer, J. M., and Zerial, M. (1999b). Phosphatidylinositol-3-OH kinases are Rab5 effectors. 
Nat Cell Biol 1, 249-252. 
Clary, D. O., Griff, I. C., and Rothman, J. E. (1990). SNAPs, a family of NSF attachment proteins 
involved in intracellular membrane fusion in animals and yeast. Cell 61, 709-721. 
 65
Coppola, T., Frantz, C., Perret-Menoud, V., Gattesco, S., Hirling, H., and Regazzi, R. (2002). 
Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis. Mol 
Biol Cell 13, 1906-1915. 
Cosson, P., and Letourneur, F. (1994). Coatomer interaction with di-lysine endoplasmic reticulum 
retention motifs. Science 263, 1629-1631. 
Cowles, C. R., Emr, S. D., and Horazdovsky, B. F. (1994). Mutations in the VPS45 gene, a SEC1 
homologue, result in vacuolar protein sorting defects and accumulation of membrane vesicles. J 
Cell Sci 107 ( Pt 12), 3449-3459. 
Craig, T. J., Evans, G. J., and Morgan, A. (2003). Physiological regulation of Munc18/nSec1 
phosphorylation on serine-313. J Neurochem 86, 1450-1457. 
Dascher, C., Ossig, R., Gallwitz, D., and Schmitt, H. D. (1991). Identification and structure of four 
yeast genes (SLY) that are able to suppress the functional loss of YPT1, a member of the RAS 
superfamily. Mol Cell Biol 11, 872-885. 
de Renzis, S., Sönnichsen, B., and Zerial, M. (2002). Divalent Rab effectors regulate the sub-
compartmental organization and sorting of early endosomes. Nat Cell Biol 4, 124-133. 
de Vries, K. J., Geijtenbeek, A., Brian, E. C., de Graan, P. N., Ghijsen, W. E., and Verhage, M. (2000). 
Dynamics of munc18-1 phosphorylation/dephosphorylation in rat brain nerve terminals. Eur J 
Neurosci 12, 385-390. 
Delgrossi, M. H., Breuza, L., Mirre, C., Chavrier, P., and Le Bivic, A. (1997). Human syntaxin 3 is 
localized apically in human intestinal cells. J Cell Sci 110 ( Pt 18), 2207-2214. 
Dell'Angelica, E. C., Klumperman, J., Stoorvogel, W., and Bonifacino, J. S. (1998). Association of the 
AP-3 adaptor complex with clathrin. Science 280, 431-434. 
Deneka, M., and van der Sluijs, P. (2002). 'Rab'ing up endosomal membrane transport. Nat Cell Biol 4, 
E33-35. 
Desnos, C., Schonn, J. S., Huet, S., Tran, V. S., El-Amraoui, A., Raposo, G., Fanget, I., Chapuis, C., 
Menasche, G., de Saint Basile, G., et al. (2003). Rab27A and its effector MyRIP link secretory 
granules to F-actin and control their motion towards release sites. J Cell Biol 163, 559-570. 
Dresbach, T., Burns, M. E., O'Connor, V., DeBello, W. M., Betz, H., and Augustine, G. J. (1998). A 
neuronal Sec1 homolog regulates neurotransmitter release at the squid giant synapse. J Neurosci 
18, 2923-2932. 
Dulubova, I., Sugita, S., Hill, S., Hosaka, M., Fernandez, I., Südhof, T. C., and Rizo, J. (1999). A 
conformational switch in syntaxin during exocytosis: role of munc18. Embo J 18, 4372-4382. 
Dulubova, I., Yamaguchi, T., Gao, Y., Min, S. W., Huryeva, I., Südhof, T. C., and Rizo, J. (2002). 
How Tlg2p/syntaxin 16 'snares' Vps45. Embo J 21, 3620-3631. 
Earles, C. A., Bai, J., Wang, P., and Chapman, E. R. (2001). The tandem C2 domains of synaptotagmin 
contain redundant Ca2+ binding sites that cooperate to engage t-SNAREs and trigger exocytosis. 
J Cell Biol 154, 1117-1123. 
Echard, A., Jollivet, F., Martinez, O., Lacapere, J. J., Rousselet, A., Janoueix-Lerosey, I., and Goud, B. 
(1998). Interaction of a Golgi-associated kinesin-like protein with Rab6. Science 279, 580-585. 
Eggenschwiler, J.T., Espinoza, E. and Anderson, K.V. (2001) Rab23 ia an essential negative regulator 
of the mouse sonic hedgehog signalling pathway. Nature 412(6843), 194-8. 
El-Amraoui, A., Schonn, J. S., Kussel-Andermann, P., Blanchard, S., Desnos, C., Henry, J. P., 
Wolfrum, U., Darchen, F., and Petit, C. (2002). MyRIP, a novel Rab effector, enables myosin 
VIIa recruitment to retinal melanosomes. EMBO Rep 3, 463-470. 
Enomaa, N., Danos, O., Peltonen, L., and Jalanko, A. (1995). Correction of deficient enzyme activity in 
a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene 
transfer. Hum Gene Ther 6, 723-731. 
Evans, T. M., Ferguson, C., Wainwright, B. J., Parton, R. G., and Wicking, C. (2003). Rab23, a 
negative regulator of hedgehog signaling, localizes to the plasma membrane and the endocytic 
pathway. Traffic 4, 869-884. 
Fasshauer, D., Antonin, W., Margittai, M., Pabst, S., and Jahn, R. (1999). Mixed and non-cognate 
SNARE complexes. Characterization of assembly and biophysical properties. J Biol Chem 274, 
15440-15446. 
Fasshauer, D., Antonin, W., Subramaniam, V., and Jahn, R. (2002). SNARE assembly and disassembly 
exhibit a pronounced hysteresis. Nat Struct Biol 9, 144-151. 
Fasshauer, D., Sutton, R. B., Brunger, A. T., and Jahn, R. (1998). Conserved structural features of the 
synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc Natl Acad 
Sci U S A 95, 15781-15786. 
Feng, Y., Press, B., and Wandinger-Ness, A. (1995). Rab 7: an important regulator of late endocytic 
membrane traffic. J Cell Biol 131, 1435-1452. 
 66
Fischer von Mollard, G., and Stevens, T. H. (1999). The Saccharomyces cerevisiae v-SNARE Vti1p is 
required for multiple membrane transport pathways to the vacuole. Mol Biol Cell 10, 1719-
1732. 
Fletcher, A. I., Shuang, R., Giovannucci, D. R., Zhang, L., Bittner, M. A., and Stuenkel, E. L. (1999). 
Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J Biol 
Chem 274, 4027-4035. 
Fouraux, M. A., Deneka, M., Ivan, V., Van Der Heijden, A., Raymackers, J., Van Suylekom, D., Van 
Venrooij, W. J., Van Der Sluijs, P., and Pruijn, G. J. (2004). rabip4' is an effector of rab5 and 
rab4 and regulates transport through early endosomes. Mol Biol Cell. 15(2):611-24. 
Fujita, Y., Sasaki, T., Fukui, K., Kotani, H., Kimura, T., Hata, Y., Südhof, T. C., Scheller, R. H., and 
Takai, Y. (1996). Phosphorylation of Munc-18/n-Sec1/rbSec1 by protein kinase C: its 
implication in regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin. J Biol Chem 
271, 7265-7268. 
Fujita, Y., Shirataki, H., Sakisaka, T., Asakura, T., Ohya, T., Kotani, H., Yokoyama, S., Nishioka, H., 
Matsuura, Y., Mizoguchi, A., Scheller R.H. and Takai, Y. (1998). Tomosyn: a syntaxin-1-
binding protein that forms a novel complex in the neurotransmitter release process. Neuron 20, 
905-915. 
Futter, C. E., Pearse, A., Hewlett, L. J., and Hopkins, C. R. (1996). Multivesicular endosomes 
containing internalized EGF-EGF receptor complexes mature and then fuse directly with 
lysosomes. J Cell Biol 132, 1011-1023. 
Gaisano, H. Y. (2000). A hypothesis: SNARE-ing the mechanisms of regulated exocytosis and 
pathologic membrane fusions in the pancreatic acinar cell. Pancreas 20, 217-226. 
Gaisano, H. Y., Klueppelberg, U. G., Pinon, D. I., Pfenning, M. A., Powers, S. P., and Miller, L. J. 
(1989). Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion. J 
Clin Invest 83, 321-325. 
Gengyo-Ando, K., Kitayama, H., Mukaida, M., and Ikawa, Y. (1996). A murine neural-specific 
homolog corrects cholinergic defects in Caenorhabditis elegans unc-18 mutants. J Neurosci 16, 
6695-6702. 
Gerst, J. E. (2003). SNARE regulators: matchmakers and matchbreakers. Biochim Biophys Acta 1641, 
99-110. 
Goldberg, J. (1999). Structural and functional analysis of the ARF1-ARFGAP complex reveals a role 
for coatomer in GTP hydrolysis. Cell 96, 893-902. 
Goldstein, L. S., and Yang, Z. (2000). Microtubule-based transport systems in neurons: the roles of 
kinesins and dyneins. Annu Rev Neurosci 23, 39-71. 
Goodman, O. B., Jr., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, 
J. H., and Benovic, J. L. (1996). Beta-arrestin acts as a clathrin adaptor in endocytosis of the 
beta2-adrenergic receptor. Nature 383, 447-450. 
Gorvel, J. P., Chavrier, P., Zerial, M., and Grüenberg, J. (1991). rab5 controls early endosome fusion in 
vitro. Cell 64, 915-925. 
Graham, M. E., Sudlow, A. W., and Burgoyne, R. D. (1997). Evidence against an acute inhibitory role 
of nSec-1 (munc-18) in late steps of regulated exocytosis in chromaffin and PC12 cells. J 
Neurochem 69, 2369-2377. 
Guo, W., Roth, D., Walch-Solimena, C., and Novick, P. (1999). The exocyst is an effector for Sec4p, 
targeting secretory vesicles to sites of exocytosis. Embo J 18, 1071-1080. 
Hata, Y., and Südhof, T. C. (1995). A novel ubiquitous form of Munc-18 interacts with multiple 
syntaxins. Use of the yeast two-hybrid system to study interactions between proteins involved in 
membrane traffic. J Biol Chem 270, 13022-13028. 
Hess, D. T., Slater, T. M., Wilson, M. C., and Skene, J. H. (1992). The 25 kDa synaptosomal-
associated protein SNAP-25 is the major methionine-rich polypeptide in rapid axonal transport 
and a major substrate for palmitoylation in adult CNS. J Neurosci 12, 4634-4641. 
Hill, K., Li, Y., Bennett, M., McKay, M., Zhu, X., Shern, J., Torre, E., Lah, J. J., Levey, A. I., and 
Kahn, R. A. (2003). Munc18 interacting proteins: ADP-ribosylation factor-dependent coat 
proteins that regulate the traffic of beta-Alzheimer's precursor protein. J Biol Chem 278, 36032-
36040. 
Hirst, J., Bright, N. A., Rous, B., and Robinson, M. S. (1999). Characterization of a fourth adaptor-
related protein complex. Mol Biol Cell 10, 2787-2802. 
Holleran, E. A., Karki, S., and Holzbaur, E. L. (1998). The role of the dynactin complex in intracellular 
motility. Int Rev Cytol 182, 69-109. 
Horiuchi, H., Lippe, R., McBride, H. M., Rubino, M., Woodman, P., Stenmark, H., Rybin, V., Wilm, 
M., Ashman, K., Mann, M., and Zerial, M. (1997). A novel Rab5 GDP/GTP exchange factor 
 67
complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell 
90, 1149-1159. 
Houng, A., Polgar, J., and Reed, G. L. (2003). Munc18-syntaxin complexes and exocytosis in human 
platelets. J Biol Chem 278, 19627-19633. 
Huang, X., Sheu, L., Tamori, Y., Trimble, W. S., and Gaisano, H. Y. (2001). Cholecystokinin-
regulated exocytosis in rat pancreatic acinar cells is inhibited by a C-terminus truncated mutant 
of SNAP-23. Pancreas 23, 125-133. 
Jacob, R., Preuss, U., Panzer, P., Alfalah, M., Quack, S., Roth, M. G., Naim, H., and Naim, H. Y. 
(1999). Hierarchy of sorting signals in chimeras of intestinal lactase-phlorizin hydrolase and the 
influenza virus hemagglutinin. J Biol Chem 274, 8061-8067. 
Johannes, L., and Goud, B. (2000). Facing inward from compartment shores: how many pathways were 
we looking for? Traffic 1, 119-123. 
Jones, S., Litt, R.J., Richardson, C.J. and Segev, N. (1995) Requirement of nucleotide exchange factor 
for Ypt1 GTPase mediated protein transport. J Cell Biol. 130(5), 1051-61. 
Jordens, I., Fernandez-Borja, M., Marsman, M., Dusseljee, S., Janssen, L., Calafat, J., Janssen, H., 
Wubbolts, R., and Neefjes, J. (2001). The Rab7 effector protein RILP controls lysosomal 
transport by inducing the recruitment of dynein-dynactin motors. Curr Biol 11, 1680-1685. 
Kamal, A., and Goldstein, L. S. (2000). Connecting vesicle transport to the cytoskeleton. Curr Opin 
Cell Biol 12, 503-508. 
Katagiri, H., Terasaki, J., Murata, T., Ishihara, H., Ogihara, T., Inukai, K., Fukushima, Y., Anai, M., 
Kikuchi, M., Miyazaki, J., and et al. (1995). A novel isoform of syntaxin-binding protein 
homologous to yeast Sec1 expressed ubiquitously in mammalian cells. J Biol Chem 270, 4963-
4966. 
Kauppi, M., Jäntti, J., and Olkkonen, V.M. (2004) The function of Sec1/Munc18 proteins: Solution of 
the mystery in sight? Topics in Current Genetics. In press 
Klenchin, V. A., and Martin, T. F. (2000). Priming in exocytosis: attaining fusion-competence after 
vesicle docking. Biochimie 82, 399-407. 
Lafer, E. M. (2002). Clathrin-protein interactions. Traffic 3, 513-520. 
Lafont, F., Verkade, P., Galli, T., Wimmer, C., Louvard, D., and Simons, K. (1999). Raft association of 
SNAP receptors acting in apical trafficking in Madin-Darby canine kidney cells. Proc Natl Acad 
Sci U S A 96, 3734-3738. 
Liljeström, P., and Garoff, H. (1991). A new generation of animal cell expression vectors based on the 
Semliki Forest virus replicon. Biotechnology (N Y) 9, 1356-1361. 
Lin, R. C., and Scheller, R. H. (2000). Mechanisms of synaptic vesicle exocytosis. Annu Rev Cell Dev 
Biol 16, 19-49. 
Lipschutz, J. H., and Mostov, K. E. (2002). Exocytosis: the many masters of the exocyst. Curr Biol 12, 
R212-214. 
Lombardi, D., Soldati, T., Riederer, M. A., Goda, Y., Zerial, M., and Pfeffer, S. R. (1993). Rab9 
functions in transport between late endosomes and the trans Golgi network. Embo J 12, 677-682. 
Low, S. H., Chapin, S. J., Weimbs, T., Komuves, L. G., Bennett, M. K., and Mostov, K. E. (1996). 
Differential localization of syntaxin isoforms in polarized Madin-Darby canine kidney cells. Mol 
Biol Cell 7, 2007-2018. 
Lütcke, A., Parton, R.G., Murphy, C., Olkkonen, V.M., Dupree, P., Valencia, A., Simons, K. and 
Zerial, M. (1994) Cloning and subcellular localization of novel rab proteins reveals polarized 
and cell type-specific expression.  J Cell Biol 107 (12), 3437-48. 
Martin-Verdeaux, S., Pombo, I., Iannascoli, B., Roa, M., Varin-Blank, N., Rivera, J., and Blank, U. 
(2003). Evidence of a role for Munc18-2 and microtubules in mast cell granule exocytosis. J Cell 
Sci 116, 325-334. 
Matlin, K. S., and Simons, K. (1984). Sorting of an apical plasma membrane glycoprotein occurs 
before it reaches the cell surface in cultured epithelial cells. J Cell Biol 99, 2131-2139. 
McBride, H. M., Rybin, V., Murphy, C., Giner, A., Teasdale, R., and Zerial, M. (1999). Oligomeric 
complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between 
EEA1 and syntaxin 13. Cell 98, 377-386. 
Menasche, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S., Wulffraat, N., Bianchi, D., 
Fischer, A., Le Deist, F., and de Saint Basile, G. (2000). Mutations in RAB27A cause Griscelli 
syndrome associated with haemophagocytic syndrome. Nat Genet 25, 173-176. 
Meresse, S., Gorvel, J. P., and Chavrier, P. (1995). The rab7 GTPase resides on a vesicular 
compartment connected to lysosomes. J Cell Sci 108 ( Pt 11), 3349-3358. 
 68
Miaczynska, M., Christoforidis, S., Giner, A., Shevchenko, A., Uttenweiler-Joseph, S., Habermann, B., 
Wilm, M., Parton, R. and Zerial, M. (2004) APPL proteins link Rab5 to nuclear signal 
transduction via an endosomal compartment. Cell 116, 445-456. 
Mills, I. G., Jones, A. T., and Clague, M. J. (1999). Regulation of endosome fusion. Mol Membr Biol 
16, 73-79. 
Misura, K. M., Scheller, R. H., and Weis, W. I. (2000). Three-dimensional structure of the neuronal-
Sec1-syntaxin 1a complex. Nature 404, 355-362. 
Mizuno, K., Kitamura, A., and Sasaki, T. (2003). Rabring7, a novel Rab7 target protein with a RING 
finger motif. Mol Biol Cell 14, 3741-3752. 
Mochida, S., Orita, S., Sakaguchi, G., Sasaki, T., and Takai, Y. (1998). Role of the Doc2 alpha-
Munc13-1 interaction in the neurotransmitter release process. Proc Natl Acad Sci U S A 95, 
11418-11422. 
Mostov, K., Su, T., and ter Beest, M. (2003). Polarized epithelial membrane traffic: conservation and 
plasticity. Nat Cell Biol 5, 287-293. 
Moyer, B. D., Allan, B. B., and Balch, W. E. (2001). Rab1 interaction with a GM130 effector complex 
regulates COPII vesicle cis--Golgi tethering. Traffic 2, 268-276. 
Naren, A. P., Nelson, D. J., Xie, W., Jovov, B., Pevsner, J., Bennett, M. K., Benos, D. J., Quick, M. W., 
and Kirk, K. L. (1997). Regulation of CFTR chloride channels by syntaxin and Munc18 
isoforms. Nature 390, 302-305. 
Nelson, W. J., and Yeaman, C. (2001). Protein trafficking in the exocytic pathway of polarized 
epithelial cells. Trends Cell Biol 11, 483-486. 
Nielsen, E., Christoforidis, S., Uttenweiler-Joseph, S., Miaczynska, M., Dewitte, F., Wilm, M., 
Hoflack, B., and Zerial, M. (2000). Rabenosyn-5, a novel Rab5 effector, is complexed with 
hVPS45 and recruited to endosomes through a FYVE finger domain. J Cell Biol 151, 601-612. 
Novick, P., Field, C., and Schekman, R. (1980). Identification of 23 complementation groups required 
for post-translational events in the yeast secretory pathway. Cell 21, 205-215. 
Novick, P., and Schekman, R. (1979). Secretion and cell-surface growth are blocked in a temperature-
sensitive mutant of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 76, 1858-1862. 
Novick, P., and Zerial, M. (1997). The diversity of Rab proteins in vesicle transport. Curr Opin Cell 
Biol 9, 496-504. 
Okamoto, M., and Südhof, T. C. (1998). Mint 3: a ubiquitous mint isoform that does not bind to 
munc18-1 or -2. Eur J Cell Biol 77, 161-165. 
Olkkonen, V. M., Dupree, P., Killisch, I., Lütcke, A., Zerial, M., and Simons, K. (1993). Molecular 
cloning and subcellular localization of three GTP-binding proteins of the rab subfamily. J Cell 
Sci 106 ( Pt 4), 1249-1261. 
Olkkonen, V. M., and Stenmark, H. (1997). Role of Rab GTPases in membrane traffic. Int Rev Cytol 
176, 1-85. 
Orci, L., Stamnes, M., Ravazzola, M., Amherdt, M., Perrelet, A., Söllner, T. H., and Rothman, J. E. 
(1997). Bidirectional transport by distinct populations of COPI-coated vesicles. Cell 90, 335-
349. 
Ossig, R., Dascher, C., Trepte, H. H., Schmitt, H. D., and Gallwitz, D. (1991). The yeast SLY gene 
products, suppressors of defects in the essential GTP-binding Ypt1 protein, may act in 
endoplasmic reticulum-to-Golgi transport. Mol Cell Biol 11, 2980-2993. 
Parlati, F., McNew, J. A., Fukuda, R., Miller, R., Söllner, T. H., and Rothman, J. E. (2000). 
Topological restriction of SNARE-dependent membrane fusion. Nature 407, 194-198. 
Payne, G. S., and Schekman, R. (1985). A test of clathrin function in protein secretion and cell growth. 
Science 230, 1009-1014. 
Peränen, J., Auvinen, P., Virta, H., Wepf, R., and Simons, K. (1996). Rab8 promotes polarized 
membrane transport through reorganization of actin and microtubules in fibroblasts. J Cell Biol 
135, 153-167. 
Peterson, M. R., Burd, C. G., and Emr, S. D. (1999). Vac1p coordinates Rab and phosphatidylinositol 
3-kinase signaling in Vps45p-dependent vesicle docking/fusion at the endosome. Curr Biol 9, 
159-162. 
Pevsner, J., Hsu, S. C., Braun, J. E., Calakos, N., Ting, A. E., Bennett, M. K., and Scheller, R. H. 
(1994). Specificity and regulation of a synaptic vesicle docking complex. Neuron 13, 353-361. 
Pfeffer, S. (2003). Membrane domains in the secretory and endocytic pathways. Cell 112, 507-517. 
Pfeffer, S. R. (1999). Transport-vesicle targeting: tethers before SNAREs. Nat Cell Biol 1, E17-22. 
Quinones, B., Riento, K., Olkkonen, V. M., Hardy, S., and Bennett, M. K. (1999). Syntaxin 2 splice 
variants exhibit differential expression patterns, biochemical properties and subcellular 
localizations. J Cell Sci 112 ( Pt 23), 4291-4304. 
 69
Rahman, A., Kamal, A., Roberts, E. A., and Goldstein, L. S. (1999). Defective kinesin heavy chain 
behavior in mouse kinesin light chain mutants. J Cell Biol 146, 1277-1288. 
Raposo, G., Cordonnier, M. N., Tenza, D., Menichi, B., Durrbach, A., Louvard, D., and Coudrier, E. 
(1999). Association of myosin I alpha with endosomes and lysosomes in mammalian cells. Mol 
Biol Cell 10, 1477-1494. 
Reed, G. L., Houng, A. K., and Fitzgerald, M. L. (1999). Human platelets contain SNARE proteins and 
a Sec1p homologue that interacts with syntaxin 4 and is phosphorylated after thrombin 
activation: implications for platelet secretion. Blood 93, 2617-2626. 
Rieder, S. E., and Emr, S. D. (1997). A novel RING finger protein complex essential for a late step in 
protein transport to the yeast vacuole. Mol Biol Cell 8, 2307-2327. 
Riento, K. (1999). Characterization of Munc-18-2, a Mammalian Sec1 Protein. Academic Dissertation. 
Riento, K., Galli, T., Jansson, S., Ehnholm, C., Lehtonen, E., and Olkkonen, V. M. (1998). Interaction 
of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells. J 
Cell Sci 111 ( Pt 17), 2681-2688. 
Riento, K., Jäntti, J., Jansson, S., Hielm, S., Lehtonen, E., Ehnholm, C., Keränen, S., and Olkkonen, V. 
M. (1996). A sec1-related vesicle-transport protein that is expressed predominantly in epithelial 
cells. Eur J Biochem 239, 638-646. 
Robinson, J. S., Klionsky, D. J., Banta, L. M., and Emr, S. D. (1988). Protein sorting in Saccharomyces 
cerevisiae: isolation of mutants defective in the delivery and processing of multiple vacuolar 
hydrolases. Mol Cell Biol 8, 4936-4948. 
Rodriguez-Boulan, E., Paskiet, K. T., Salas, P. J., and Bard, E. (1984). Intracellular transport of 
influenza virus hemagglutinin to the apical surface of Madin-Darby canine kidney cells. J Cell 
Biol 98, 308-319. 
Rothman, J. E. (1994). Mechanisms of intracellular protein transport. Nature 372, 55-63. 
Rothman, J. E., and Wieland, F. T. (1996). Protein sorting by transport vesicles. Science 272, 227-234. 
Sacher, M., Barrowman, J., Wang, W., Horecka, J., Zhang, Y., Pypaert, M., and Ferro-Novick, S. 
(2001). TRAPP I implicated in the specificity of tethering in ER-to-Golgi transport. Mol Cell 7, 
433-442. 
Sandvig, K., and van Deurs, B. (2002). Transport of protein toxins into cells: pathways used by ricin, 
cholera toxin and Shiga toxin. FEBS Lett 529, 49-53. 
Sapperstein, S. K., Lupashin, V. V., Schmitt, H. D., and Waters, M. G. (1996). Assembly of the ER to 
Golgi SNARE complex requires Uso1p. J Cell Biol 132, 755-767. 
Sassa, T., Harada, S., Ogawa, H., Rand, J. B., Maruyama, I. N., and Hosono, R. (1999). Regulation of 
the UNC-18-Caenorhabditis elegans syntaxin complex by UNC-13. J Neurosci 19, 4772-4777. 
Sassa, T., Ogawa, H., Kimoto, M., and Hosono, R. (1996). The synaptic protein UNC-18 is 
phosphorylated by protein kinase C. Neurochem Int 29, 543-552. 
Sato, T. K., Rehling, P., Peterson, M. R., and Emr, S. D. (2000). Class C Vps protein complex regulates 
vacuolar SNARE pairing and is required for vesicle docking/fusion. Mol Cell 6, 661-671. 
Schraw, T. D., Lemons, P. P., Dean, W. L., and Whiteheart, S. W. (2003). A role for Sec1/Munc18 
proteins in platelet exocytosis. Biochem J 374, 207-217. 
Schroer, T. A., and Sheetz, M. P. (1991). Two activators of microtubule-based vesicle transport. J Cell 
Biol 115, 1309-1318. 
Schulze, K. L., Broadie, K., Perin, M. S., and Bellen, H. J. (1995). Genetic and electrophysiological 
studies of Drosophila syntaxin-1A demonstrate its role in nonneuronal secretion and 
neurotransmission. Cell 80, 311-320. 
Schulze, K. L., Littleton, J. T., Salzberg, A., Halachmi, N., Stern, M., Lev, Z., and Bellen, H. J. (1994). 
rop, a Drosophila homolog of yeast Sec1 and vertebrate n-Sec1/Munc-18 proteins, is a negative 
regulator of neurotransmitter release in vivo. Neuron 13, 1099-1108. 
Seachrist, J. L., Laporte, S. A., Dale, L. B., Babwah, A. V., Caron, M. G., Anborgh, P. H., and 
Ferguson, S. S. (2002). Rab5 association with the angiotensin II type 1A receptor promotes 
Rab5 GTP binding and vesicular fusion. J Biol Chem 277, 679-685. 
Seals, D. F., Eitzen, G., Margolis, N., Wickner, W. T., and Price, A. (2000). A Ypt/Rab effector 
complex containing the Sec1 homolog Vps33p is required for homotypic vacuole fusion. Proc 
Natl Acad Sci U S A 97, 9402-9407. 
Sevrioukov, E. A., He, J. P., Moghrabi, N., Sunio, A., and Kramer, H. (1999). A role for the deep 
orange and carnation eye color genes in lysosomal delivery in Drosophila. Mol Cell 4, 479-486. 
Shorter, J., Beard, M. B., Seemann, J., Dirac-Svejstrup, A. B., and Warren, G. (2002). Sequential 
tethering of Golgins and catalysis of SNAREpin assembly by the vesicle-tethering protein p115. 
J Cell Biol 157, 45-62. 
 70
Simonsen, A., Gaullier, J. M., D'Arrigo, A., and Stenmark, H. (1999). The Rab5 effector EEA1 
interacts directly with syntaxin-6. J Biol Chem 274, 28857-28860. 
Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J. M., Brech, A., Callaghan, J., Toh, B. H., 
Murphy, C., Zerial, M., and Stenmark, H. (1998). EEA1 links PI(3)K function to Rab5 
regulation of endosome fusion. Nature 394, 494-498. 
Skehel, J. J., and Wiley, D. C. (1998). Coiled coils in both intracellular vesicle and viral membrane 
fusion. Cell 95, 871-874. 
Söllner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993a). A protein 
assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic 
vesicle docking, activation, and fusion. Cell 75, 409-418. 
Söllner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and 
Rothman, J. E. (1993b). SNAP receptors implicated in vesicle targeting and fusion. Nature 362, 
318-324. 
Sönnichsen, B., De Renzis, S., Nielsen, E., Rietdorf, J., and Zerial, M. (2000). Distinct membrane 
domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, 
Rab5, and Rab11. J Cell Biol 149, 901-914. 
Springer, S., and Schekman, R. (1998). Nucleation of COPII vesicular coat complex by endoplasmic 
reticulum to Golgi vesicle SNAREs. Science 281, 698-700. 
Springer, S., Spang, A., and Schekman, R. (1999). A primer on vesicle budding. Cell 97, 145-148. 
Spurlin, B. A., Thomas, R. M., Nevins, A. K., Kim, H. J., Kim, Y. J., Noh, H. L., Shulman, G. I., Kim, 
J. K., and Thurmond, D. C. (2003). Insulin resistance in tetracycline-repressible Munc18c 
transgenic mice. Diabetes 52, 1910-1917. 
Stein, M., Wandinger-Ness, A., and Roitbak, T. (2002). Altered trafficking and epithelial cell polarity 
in disease. Trends Cell Biol 12, 374-381. 
Stein, M., Feng, Y., Cooper, K.L., Welford, A.M. and Wardinger-Ness, A. (2003) Human VPS34 and 
p150 are Rab7 interacting partners. Traffic 4, 754-771. 
Stenmark, H., and Olkkonen, V. M. (2001). The Rab GTPase family. Genome Biol 2, REVIEWS3007. 
Stenmark, H., Parton, R. G., Steele-Mortimer, O., Lutcke, A., Gruenberg, J., and Zerial, M. (1994). 
Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. Embo J 13, 1287-
1296. 
Stenmark, H., Vitale, G., Ullrich, O., and Zerial, M. (1995). Rabaptin-5 is a direct effector of the small 
GTPase Rab5 in endocytic membrane fusion. Cell 83, 423-432. 
Sutter, G., Ohlmann, M., and Erfle, V. (1995). Non-replicating vaccinia vector efficiently expresses 
bacteriophage T7 RNA polymerase. FEBS Lett 371, 9-12. 
Tall, G. G., Hama, H., DeWald, D. B., and Horazdovsky, B. F. (1999). The phosphatidylinositol 3-
phosphate binding protein Vac1p interacts with a Rab GTPase and a Sec1p homologue to 
facilitate vesicle-mediated vacuolar protein sorting. Mol Biol Cell 10, 1873-1889. 
Tamori, Y., Kawanishi, M., Niki, T., Shinoda, H., Araki, S., Okazawa, H., and Kasuga, M. (1998). 
Inhibition of insulin-induced GLUT4 translocation by Munc18c through interaction with 
syntaxin4 in 3T3-L1 adipocytes. J Biol Chem 273, 19740-19746. 
Tan, P. K., Davis, N. G., Sprague, G. F., and Payne, G. S. (1993). Clathrin facilitates the internalization 
of seven transmembrane segment receptors for mating pheromones in yeast. J Cell Biol 123, 
1707-1716. 
Tellam, J. T., Macaulay, S. L., McIntosh, S., Hewish, D. R., Ward, C. W., and James, D. E. (1997). 
Characterization of Munc-18c and syntaxin-4 in 3T3-L1 adipocytes. Putative role in insulin-
dependent movement of GLUT-4. J Biol Chem 272, 6179-6186. 
Tellam, J. T., McIntosh, S., and James, D. E. (1995). Molecular identification of two novel Munc-18 
isoforms expressed in non-neuronal tissues. J Biol Chem 270, 5857-5863. 
TerBush, D. R., Maurice, T., Roth, D., and Novick, P. (1996). The Exocyst is a multiprotein complex 
required for exocytosis in Saccharomyces cerevisiae. Embo J 15, 6483-6494. 
Thurmond, D. C., Ceresa, B. P., Okada, S., Elmendorf, J. S., Coker, K., and Pessin, J. E. (1998). 
Regulation of insulin-stimulated GLUT4 translocation by Munc18c in 3T3L1 adipocytes. J Biol 
Chem 273, 33876-33883. 
Thurmond, D. C., Kanzaki, M., Khan, A. H., and Pessin, J. E. (2000). Munc18c function is required for 
insulin-stimulated plasma membrane fusion of GLUT4 and insulin-responsive amino peptidase 
storage vesicles. Mol Cell Biol 20, 379-388. 
Tikkanen, R., Peltola, M., Oinonen, C., Rouvinen, J., and Peltonen, L. (1997). Several cooperating 
binding sites mediate the interaction of a lysosomal enzyme with phosphotransferase. Embo J 
16, 6684-6693. 
 71
Toonen, R. F., and Verhage, M. (2003). Vesicle trafficking: pleasure and pain from SM genes. Trends 
Cell Biol 13, 177-186. 
Touchot, N., Chardin, P., and Tavitian, A. (1987). Four additional members of the ras gene superfamily 
isolated by an oligonucleotide strategy: molecular cloning of YPT-related cDNAs from a rat 
brain library. Proc Natl Acad Sci U S A 84, 8210-8214. 
Ullrich, O., Reinsch, S., Urbe, S., Zerial, M., and Parton, R. G. (1996). Rab11 regulates recycling 
through the pericentriolar recycling endosome. J Cell Biol 135, 913-924. 
Wada, Y., Kitamoto, K., Kanbe, T., Tanaka, K., and Anraku, Y. (1990). The SLP1 gene of 
Saccharomyces cerevisiae is essential for vacuolar morphogenesis and function. Mol Cell Biol 
10, 2214-2223. 
van der Sluijs, P., Hull, M., Webster, P., Male, P., Goud, B., and Mellman, I. (1992). The small GTP-
binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 70, 729-740. 
Waters, M. G., and Hughson, F. M. (2000). Membrane tethering and fusion in the secretory and 
endocytic pathways. Traffic 1, 588-597. 
Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Söllner, T. H., 
and Rothman, J. E. (1998). SNAREpins: minimal machinery for membrane fusion. Cell 92, 759-
772. 
Verhage, M., de Vries, K. J., Roshol, H., Burbach, J. P., Gispen, W. H., and Südhof, T. C. (1997). 
DOC2 proteins in rat brain: complementary distribution and proposed function as vesicular 
adapter proteins in early stages of secretion. Neuron 18, 453-461. 
Verhage, M., Maia, A. S., Plomp, J. J., Brussaard, A. B., Heeroma, J. H., Vermeer, H., Toonen, R. F., 
Hammer, R. E., van den Berg, T. K., Missler, M., Geuze, H.J., and Südhof,  T.C. (2000). 
Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287, 864-
869. 
White, J., Johannes, L., Mallard, F., Girod, A., Grill, S., Reinsch, S., Keller, P., Tzschaschel, B., 
Echard, A., Goud, B., and Stelzer, E. H. (1999). Rab6 coordinates a novel Golgi to ER 
retrograde transport pathway in live cells. J Cell Biol 147, 743-760. 
Whyte, J. R., and Munro, S. (2002). Vesicle tethering complexes in membrane traffic. J Cell Sci 115, 
2627-2637. 
Widberg, C. H., Bryant, N. J., Girotti, M., Rea, S., and James, D. E. (2003). Tomosyn interacts with the 
t-SNAREs syntaxin4 and SNAP23 and plays a role in insulin-stimulated GLUT4 translocation. J 
Biol Chem 278, 35093-35101. 
Wilson, D.W., Wilcox, C.A., Flynn, G.C., Chen, E., Kuang, W.-J., Henzel, W.J., Block, M.R., Ullrich, 
A. and Rothman, J.E. (1989) A fusion protein required for vesicle-mediated transport in both 
mammalian cells and yeast. Nature 339l, 355-359 
Vitale, G., Rybin, V., Christoforidis, S., Thornqvist, P., McCaffrey, M., Stenmark, H., and Zerial, M. 
(1998). Distinct Rab-binding domains mediate the interaction of Rabaptin-5 with GTP-bound 
Rab4 and Rab5. Embo J 17, 1941-1951. 
Voets, T., Toonen, R. F., Brian, E. C., de Wit, H., Moser, T., Rettig, J., Südhof, T. C., Neher, E., and 
Verhage, M. (2001). Munc18-1 promotes large dense-core vesicle docking. Neuron 31, 581-591. 
Wu, M. N., Littleton, J. T., Bhat, M. A., Prokop, A., and Bellen, H. J. (1998). ROP, the Drosophila 
Sec1 homolog, interacts with syntaxin and regulates neurotransmitter release in a dosage-
dependent manner. Embo J 17, 127-139. 
Yamaguchi, T., Dulubova, I., Min, S. W., Chen, X., Rizo, J., and Südhof, T. C. (2002). Sly1 binds to 
Golgi and ER syntaxins via a conserved N-terminal peptide motif. Dev Cell 2, 295-305. 
Yang, C., Coker, K. J., Kim, J. K., Mora, S., Thurmond, D. C., Davis, A. C., Yang, B., Williamson, R. 
A., Shulman, G. I., and Pessin, J. E. (2001). Syntaxin 4 heterozygous knockout mice develop 
muscle insulin resistance. J Clin Invest 107, 1311-1318. 
Zerial, M., and McBride, H. (2001). Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2, 
107-117. 
Zuk, P. A., and Elferink, L. A. (1999). Rab15 mediates an early endocytic event in Chinese hamster 
ovary cells. J Biol Chem 274, 22303-22312. 
Zurzolo, C., Polistina, C., Saini, M., Gentile, R., Aloj, L., Migliaccio, G., Bonatti, S., and Nitsch, L. 
(1992). Opposite polarity of virus budding and of viral envelope glycoprotein distribution in 
epithelial cells derived from different tissues. J Cell Biol 117, 551-564. 
 
